DCAMKL1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A0MZ66 | S473 | Sugiyama | SHTN1 KIAA1598 | LGtLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADss |
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| O15075 | S151 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | CGSIEPFKKLEYTKNVNPNWsVNVKTTSAsRAVssLATAKG |
| O15075 | S160 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | LEYTKNVNPNWsVNVKTTSAsRAVssLATAKGsPsEVRENK |
| O15075 | S164 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | KNVNPNWsVNVKTTSAsRAVssLATAKGsPsEVRENKDFIR |
| O15075 | S165 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | NVNPNWsVNVKTTSAsRAVssLATAKGsPsEVRENKDFIRP |
| O15075 | S172 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | VNVKTTSAsRAVssLATAKGsPsEVRENKDFIRPKLVTIIR |
| O15075 | S174 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | VKTTSAsRAVssLATAKGsPsEVRENKDFIRPKLVTIIRSG |
| O15075 | S274 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | IFIACGPEKFRYQDDFLLDEsECRVVKSTSYTKIASSSRRS |
| O15075 | S438 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | LKIIKKSKCRGKEHMIQNEVsILRRVKHPNIVLLIEEMDVP |
| O15075 | S51 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | PsPtHsAHCSFYRTRtLQtLsSEKKAKKVRFYRNGDRYFKG |
| O15075 | S96 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | ISPDRFRSFEALLADLTRTLsDNVNLPQGVRTIYTIDGLKK |
| O15075 | T395 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | VSEEGFQIPATITERYKVGRtIGDGNFAVVKECVERSTARE |
| O15075 | T46 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | RVNGLPsPtHsAHCSFYRTRtLQtLsSEKKAKKVRFYRNGD |
| O15075 | T49 | Sugiyama | DCLK1 DCAMKL1 DCDC3A KIAA0369 | GLPsPtHsAHCSFYRTRtLQtLsSEKKAKKVRFYRNGDRYF |
| O15078 | S1159 | Sugiyama | CEP290 BBS14 KIAA0373 NPHP6 | LELEKNEMELKVEVSKLREIsDIARRQVEILNAQQQSRDKE |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43615 | S193 | Sugiyama | TIMM44 MIMT44 TIM44 | TAAFRALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEF |
| O43707 | T69 | Sugiyama | ACTN4 | EKQQRKTFTAWCNsHLRKAGtQIENIDEDFRDGLKLMLLLE |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O60343 | S486 | Sugiyama | TBC1D4 AS160 KIAA0603 | ERIEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPVS |
| O60664 | T216 | Sugiyama | PLIN3 M6PRBP1 TIP47 | sEEWADNHLPLTDAELARIAtsLDGFDVAsVQQQRQEQSyF |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75391 | S57 | Sugiyama | SPAG7 | LQEQEKQQKVEFRKRMEKEVsDFIQDsGQIKKKFQPMNKIE |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O96019 | S233 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | MNIELVPPYMIASKEAVREGsPANWKRKEKLPQVTRSWHNY |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00441 | S108 | Sugiyama | SOD1 | VtADKDGVADVsIEDsVIsLsGDHCIIGRTLVVHEKADDLG |
| P00441 | S99 | Sugiyama | SOD1 | ERHVGDLGNVtADKDGVADVsIEDsVIsLsGDHCIIGRTLV |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07384 | S474 | Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09972 | S17 | Sugiyama | ALDOC ALDC | ____MPHSYPALSAEQKKELsDIALRIVAPGKGILAADEsV |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20290 | S126 | Sugiyama | BTF3 NACB OK/SW-cl.8 | VNMFTNQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEM |
| P20290 | T131 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsIL |
| P20290 | T140 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQLGADsLt |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P22059 | S240 | Sugiyama | OSBP OSBP1 | DLSTCNDLIAKHGTALQRsLsELEsLKLPAESNEKIKQVNE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P35579 | S1915 | Sugiyama | MYH9 | KLQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMA |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P40926 | T179 | Sugiyama | MDH2 | GVYNPNKIFGVTTLDIVRANtFVAELKGLDPARVNVPVIGG |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46940 | S343 | Sugiyama | IQGAP1 KIAA0051 | ALFRALQsPALGLRGLQQQNsDWYLKQLLSDKQQKRQsGQT |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P50454 | S138 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEH |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52789 | S889 | Sugiyama | HK2 | PHFAKVMHETVKDLAPKCDVsFLQsEDGSGKGAALITAVAC |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60842 | S394 | Sugiyama | EIF4A1 DDX2A EIF4A | NMVTEEDKRTLRDIEtFyNtsIEEMPLNVADLI________ |
| P60842 | T393 | Sugiyama | EIF4A1 DDX2A EIF4A | INMVTEEDKRTLRDIEtFyNtsIEEMPLNVADLI_______ |
| P60842 | Y391 | Sugiyama | EIF4A1 DDX2A EIF4A | VAINMVTEEDKRTLRDIEtFyNtsIEEMPLNVADLI_____ |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61081 | T176 | Sugiyama | UBE2M UBC12 | NRRLFEQNVQRSMRGGyIGstyFERCLK_____________ |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62753 | T34 | Sugiyama | RPS6 OK/SW-cl.2 | KLIEVDDERKLRtFyEKRMAtEVAADALGEEWKGYVVRIsG |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02790 | T42 | Sugiyama | FKBP4 FKBP52 | GVDIsPKQDEGVLKVIKREGtGTEMPMIGDRVFVHYTGWLL |
| Q04917 | T31 | Sugiyama | YWHAH YWHA1 | ARLAEQAERyDDMAsAMKAVtELNEPLsNEDRNLLsVAyKN |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06210 | T262 | Sugiyama | GFPT1 GFAT GFPT | sQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDAS |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14677 | S210 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | KNKSAFPFSDKLGELsDKIGstIDDtIsKFRRKDREDsPER |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15121 | S116 | Sugiyama | PEA15 | DtKLtRIPsAKKYKDIIRQPsEEEIIKLAPPPKKA______ |
| Q16531 | T1125 | Sugiyama | DDB1 XAP1 | MQEVVANLQYDDGSGMKREAtADDLIKVVEELtRIH_____ |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q2TAA2 | S241 | Sugiyama | IAH1 | SSLPLLLPYWRDVAEAKPELsLLGDGDH_____________ |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q5SSJ5 | S227 | Sugiyama | HP1BP3 | LKRELNRGVIKQVKGKGAsGsFVVVQKSRKTPQKSRNRKNR |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IX12 | S343 | PSP | CCAR1 CARP1 DIS | ERERRRSRERSPQRKRSRERsPRRERERSPRRVRRVVPRYT |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8WVC0 | T477 | Sugiyama | LEO1 RDL | FDVYKAPLQGDHNHLFIRQGtGLQGQAVFKTKLTFRPHstD |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q99613 | S754 | Sugiyama | EIF3C EIF3S8 | REHVVAASKAMKMGDWKTCHsFIINEKMNGKVWDLFPEADK |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NZL9 | S9 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | ____________MVGREKELsIHFVPGsCRLVEEEVNIPNR |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
| Q9Y5B9 | S650 | Sugiyama | SUPT16H FACT140 FACTP140 | KRYKTREAEEKEKEGIVKQDsLVINLNRsNPKLKDLYIRPN |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 1.609192e-10 | 9.793 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.507339e-09 | 8.601 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.446294e-08 | 7.611 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.291544e-08 | 7.640 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.602076e-08 | 7.585 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.213406e-08 | 7.207 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.255373e-07 | 6.647 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.359127e-07 | 6.361 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.248462e-07 | 6.372 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.289517e-06 | 5.890 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.503118e-06 | 5.602 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.819550e-06 | 5.317 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.765150e-06 | 5.239 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.029098e-06 | 5.220 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.429329e-06 | 5.129 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.865291e-06 | 5.052 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.349738e-05 | 4.629 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.091501e-05 | 4.510 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.188640e-05 | 4.208 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.735548e-05 | 4.172 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.417276e-05 | 4.075 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.884378e-05 | 4.005 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.054528e-04 | 3.977 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.200341e-04 | 3.921 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.227112e-04 | 3.911 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.224316e-04 | 3.912 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.224316e-04 | 3.912 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.179978e-04 | 3.928 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.362214e-04 | 3.866 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.585684e-04 | 3.800 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.806603e-04 | 3.743 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.133428e-04 | 3.671 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.171085e-04 | 3.663 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.216608e-04 | 3.654 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.346631e-04 | 3.630 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.501956e-04 | 3.602 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.542825e-04 | 3.595 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.768318e-04 | 3.558 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.763787e-04 | 3.558 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.782164e-04 | 3.556 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.028708e-04 | 3.519 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.263599e-04 | 3.486 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.430753e-04 | 3.465 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.710996e-04 | 3.431 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.848963e-04 | 3.415 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.441999e-04 | 3.352 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.819405e-04 | 3.317 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.278008e-04 | 3.278 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.532246e-04 | 3.257 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.532246e-04 | 3.257 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.532246e-04 | 3.257 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.240736e-04 | 3.281 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.036052e-04 | 3.298 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.333286e-04 | 3.273 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.532246e-04 | 3.257 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.539676e-04 | 3.257 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.503084e-04 | 3.125 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.414443e-04 | 3.130 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.906646e-04 | 3.102 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.802150e-04 | 3.108 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.671319e-04 | 3.062 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.035151e-03 | 2.985 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.019543e-03 | 2.992 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.059883e-03 | 2.975 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.083991e-03 | 2.965 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.073884e-03 | 2.969 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.032244e-03 | 2.986 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.125403e-03 | 2.949 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.197308e-03 | 2.922 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.264575e-03 | 2.898 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.300367e-03 | 2.886 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.317914e-03 | 2.880 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.400230e-03 | 2.854 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.490574e-03 | 2.827 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.490574e-03 | 2.827 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.505632e-03 | 2.822 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.525609e-03 | 2.817 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.864451e-03 | 2.729 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.944032e-03 | 2.711 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.021498e-03 | 2.694 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.167109e-03 | 2.664 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.313383e-03 | 2.636 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.383820e-03 | 2.623 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.384317e-03 | 2.623 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.799898e-03 | 2.553 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.120922e-03 | 2.506 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.947705e-03 | 2.531 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.105875e-03 | 2.508 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.120922e-03 | 2.506 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.138791e-03 | 2.503 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.158707e-03 | 2.500 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.284032e-03 | 2.484 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.510959e-03 | 2.455 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.602542e-03 | 2.443 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.602542e-03 | 2.443 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.593793e-03 | 2.444 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.510959e-03 | 2.455 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.788277e-03 | 2.422 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.975710e-03 | 2.401 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.985371e-03 | 2.400 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.096205e-03 | 2.388 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.415482e-03 | 2.355 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.415482e-03 | 2.355 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.563002e-03 | 2.341 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.878827e-03 | 2.312 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.892533e-03 | 2.310 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.996952e-03 | 2.301 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.029806e-03 | 2.298 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.192222e-03 | 2.285 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.329565e-03 | 2.273 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.198185e-03 | 2.284 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.192222e-03 | 2.285 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.329565e-03 | 2.273 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.420777e-03 | 2.266 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.472043e-03 | 2.262 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.547233e-03 | 2.256 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.808956e-03 | 2.236 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.042896e-03 | 2.219 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.302902e-03 | 2.200 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.302902e-03 | 2.200 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.302902e-03 | 2.200 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.482858e-03 | 2.188 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.513622e-03 | 2.186 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.562020e-03 | 2.183 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.741053e-03 | 2.171 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.396673e-03 | 2.131 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.631526e-03 | 2.117 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.631526e-03 | 2.117 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.636023e-03 | 2.117 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.636023e-03 | 2.117 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.839047e-03 | 2.106 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.277847e-03 | 2.082 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.343213e-03 | 2.079 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.235274e-03 | 2.035 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.235274e-03 | 2.035 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.982506e-03 | 2.001 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.012324e-02 | 1.995 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.390130e-03 | 2.027 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.111318e-02 | 1.954 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.196706e-02 | 1.922 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.225760e-02 | 1.912 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.260610e-02 | 1.899 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.273554e-02 | 1.895 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.273554e-02 | 1.895 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.335068e-02 | 1.874 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.395977e-02 | 1.855 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.413329e-02 | 1.850 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.562173e-02 | 1.806 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.562173e-02 | 1.806 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.456477e-02 | 1.837 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.527231e-02 | 1.816 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.492673e-02 | 1.826 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.533049e-02 | 1.814 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.564952e-02 | 1.805 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.564952e-02 | 1.805 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.601262e-02 | 1.796 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.621643e-02 | 1.790 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.676254e-02 | 1.776 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.691024e-02 | 1.772 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.025091e-02 | 1.694 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.025091e-02 | 1.694 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.025091e-02 | 1.694 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.025091e-02 | 1.694 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.003048e-02 | 1.698 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.129602e-02 | 1.672 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.129602e-02 | 1.672 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.129602e-02 | 1.672 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.129602e-02 | 1.672 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.129602e-02 | 1.672 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.129602e-02 | 1.672 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.129602e-02 | 1.672 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.766501e-02 | 1.753 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.766501e-02 | 1.753 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.766501e-02 | 1.753 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.794710e-02 | 1.746 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.953322e-02 | 1.709 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.097761e-02 | 1.678 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.825436e-02 | 1.739 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.792557e-02 | 1.747 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.122893e-02 | 1.673 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.878128e-02 | 1.726 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.894010e-02 | 1.723 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.020961e-02 | 1.694 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.842033e-02 | 1.735 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.107340e-02 | 1.676 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.805114e-02 | 1.743 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.842033e-02 | 1.735 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.977402e-02 | 1.704 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.213350e-02 | 1.655 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.347967e-02 | 1.629 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.381895e-02 | 1.623 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.381895e-02 | 1.623 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.433026e-02 | 1.614 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.539233e-02 | 1.595 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.539233e-02 | 1.595 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.550327e-02 | 1.593 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.752456e-02 | 1.560 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.826146e-02 | 1.549 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.826146e-02 | 1.549 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.177776e-02 | 1.498 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.177776e-02 | 1.498 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.177776e-02 | 1.498 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.177776e-02 | 1.498 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.177776e-02 | 1.498 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.177776e-02 | 1.498 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.177776e-02 | 1.498 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.177776e-02 | 1.498 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.177776e-02 | 1.498 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.177776e-02 | 1.498 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.177776e-02 | 1.498 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.177776e-02 | 1.498 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.975116e-02 | 1.526 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.975116e-02 | 1.526 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.074320e-02 | 1.512 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.974800e-02 | 1.527 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.238732e-02 | 1.490 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.238732e-02 | 1.490 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.222453e-02 | 1.492 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.252019e-02 | 1.488 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.259979e-02 | 1.487 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.259979e-02 | 1.487 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.292976e-02 | 1.482 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.292976e-02 | 1.482 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.292976e-02 | 1.482 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.324684e-02 | 1.478 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.449080e-02 | 1.462 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.449080e-02 | 1.462 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.449080e-02 | 1.462 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.449080e-02 | 1.462 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.449080e-02 | 1.462 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.600358e-02 | 1.444 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.662558e-02 | 1.436 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.662558e-02 | 1.436 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.665634e-02 | 1.436 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.712754e-02 | 1.430 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.170805e-02 | 1.380 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.170805e-02 | 1.380 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.170805e-02 | 1.380 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.267660e-02 | 1.370 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.267660e-02 | 1.370 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.906918e-02 | 1.408 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.906382e-02 | 1.408 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.906382e-02 | 1.408 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.143848e-02 | 1.383 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.217095e-02 | 1.375 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.054343e-02 | 1.392 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.170805e-02 | 1.380 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.766876e-02 | 1.424 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.766876e-02 | 1.424 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.766876e-02 | 1.424 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.387687e-02 | 1.358 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.017723e-02 | 1.396 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.170805e-02 | 1.380 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.914659e-02 | 1.407 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.054343e-02 | 1.392 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.036248e-02 | 1.394 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.455603e-02 | 1.351 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.476408e-02 | 1.349 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.490101e-02 | 1.348 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.546215e-02 | 1.342 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.546215e-02 | 1.342 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.546215e-02 | 1.342 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.595044e-02 | 1.338 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.595044e-02 | 1.338 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.595044e-02 | 1.338 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.595044e-02 | 1.338 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.595044e-02 | 1.338 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.595044e-02 | 1.338 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 4.626264e-02 | 1.335 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.626264e-02 | 1.335 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.626264e-02 | 1.335 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.626264e-02 | 1.335 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.626264e-02 | 1.335 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.626264e-02 | 1.335 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.745132e-02 | 1.324 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.756410e-02 | 1.323 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.773235e-02 | 1.321 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.859521e-02 | 1.313 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.935335e-02 | 1.307 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.935335e-02 | 1.307 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.966078e-02 | 1.304 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.253101e-02 | 1.280 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.636978e-02 | 1.249 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.636978e-02 | 1.249 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.636978e-02 | 1.249 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.838097e-02 | 1.234 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.787007e-02 | 1.238 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.966007e-02 | 1.224 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.324478e-02 | 1.199 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.339832e-02 | 1.272 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.353404e-02 | 1.271 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.636978e-02 | 1.249 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.590537e-02 | 1.253 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.339832e-02 | 1.272 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.141478e-02 | 1.212 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.297446e-02 | 1.201 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.718633e-02 | 1.243 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.838097e-02 | 1.234 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.762938e-02 | 1.239 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.110380e-02 | 1.214 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.046032e-02 | 1.219 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.341740e-02 | 1.272 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.966007e-02 | 1.224 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.302522e-02 | 1.276 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.904323e-02 | 1.229 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.617352e-02 | 1.250 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.459540e-02 | 1.190 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.459540e-02 | 1.190 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.744277e-02 | 1.171 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.744277e-02 | 1.171 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.804715e-02 | 1.167 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.951861e-02 | 1.158 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 7.084895e-02 | 1.150 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.187043e-02 | 1.143 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.242802e-02 | 1.140 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.327957e-02 | 1.135 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.327957e-02 | 1.135 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.327957e-02 | 1.135 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.327957e-02 | 1.135 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.327957e-02 | 1.135 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.412384e-02 | 1.130 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.431615e-02 | 1.129 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.431615e-02 | 1.129 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.431615e-02 | 1.129 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.431615e-02 | 1.129 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.456695e-02 | 1.127 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.456695e-02 | 1.127 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.456695e-02 | 1.127 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 8.408664e-02 | 1.075 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 8.408664e-02 | 1.075 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 8.408664e-02 | 1.075 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 9.326748e-02 | 1.030 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.326748e-02 | 1.030 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.542142e-02 | 1.068 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.542142e-02 | 1.068 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.482267e-02 | 1.126 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.716967e-02 | 1.060 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.006540e-02 | 1.097 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 8.622484e-02 | 1.064 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.706970e-02 | 1.113 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.802063e-02 | 1.108 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.622484e-02 | 1.064 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.016941e-02 | 1.096 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.777884e-02 | 1.109 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.831678e-02 | 1.054 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.244032e-02 | 1.034 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.111366e-02 | 1.091 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.831678e-02 | 1.054 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.777884e-02 | 1.109 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.622484e-02 | 1.064 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 8.408664e-02 | 1.075 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.072274e-02 | 1.042 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.843024e-02 | 1.106 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.715336e-02 | 1.060 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.117237e-02 | 1.040 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 9.086787e-02 | 1.042 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.935880e-02 | 1.100 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.289556e-02 | 1.032 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.423372e-02 | 1.075 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.111366e-02 | 1.091 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.048871e-02 | 1.094 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 9.326748e-02 | 1.030 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.048871e-02 | 1.094 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.198479e-02 | 1.086 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 9.332272e-02 | 1.030 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 9.332272e-02 | 1.030 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 9.332272e-02 | 1.030 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 9.332272e-02 | 1.030 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 9.345034e-02 | 1.029 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 9.345034e-02 | 1.029 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.367220e-02 | 1.028 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.420505e-02 | 1.026 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.543722e-02 | 1.020 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.543722e-02 | 1.020 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.582348e-02 | 1.019 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.592199e-02 | 1.018 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.616994e-02 | 1.017 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.640027e-02 | 1.016 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.935064e-02 | 1.003 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.007742e-01 | 0.997 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.012732e-01 | 0.995 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.014643e-01 | 0.994 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.015721e-01 | 0.993 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.015721e-01 | 0.993 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.040842e-01 | 0.983 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.040842e-01 | 0.983 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.045089e-01 | 0.981 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.050186e-01 | 0.979 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.050512e-01 | 0.979 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.087673e-01 | 0.964 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.089390e-01 | 0.963 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.089390e-01 | 0.963 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.095951e-01 | 0.960 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.097236e-01 | 0.960 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.147390e-01 | 0.940 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.152651e-01 | 0.938 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.184532e-01 | 0.926 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.184532e-01 | 0.926 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.184532e-01 | 0.926 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.564177e-01 | 0.806 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.564177e-01 | 0.806 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.564177e-01 | 0.806 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.564177e-01 | 0.806 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.564177e-01 | 0.806 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.489973e-01 | 0.827 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.489973e-01 | 0.827 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.489973e-01 | 0.827 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.489973e-01 | 0.827 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.570587e-01 | 0.804 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.570587e-01 | 0.804 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.503042e-01 | 0.823 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.402096e-01 | 0.853 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.402096e-01 | 0.853 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.295659e-01 | 0.888 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.192607e-01 | 0.924 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.192607e-01 | 0.924 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.384244e-01 | 0.859 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.384244e-01 | 0.859 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.384244e-01 | 0.859 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.384244e-01 | 0.859 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.262467e-01 | 0.899 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.589794e-01 | 0.799 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.589794e-01 | 0.799 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.589794e-01 | 0.799 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.589794e-01 | 0.799 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.441321e-01 | 0.841 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.441321e-01 | 0.841 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.309744e-01 | 0.883 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.192537e-01 | 0.924 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.372417e-01 | 0.863 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.256619e-01 | 0.901 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.249826e-01 | 0.903 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.366649e-01 | 0.864 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.346375e-01 | 0.871 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.383545e-01 | 0.859 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.364470e-01 | 0.865 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.458446e-01 | 0.836 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.306117e-01 | 0.884 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.306117e-01 | 0.884 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.510341e-01 | 0.821 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.499081e-01 | 0.824 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.341145e-01 | 0.873 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.242876e-01 | 0.906 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.589794e-01 | 0.799 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.454678e-01 | 0.837 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.503042e-01 | 0.823 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.519129e-01 | 0.818 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.458446e-01 | 0.836 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.377346e-01 | 0.861 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.192607e-01 | 0.924 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.295659e-01 | 0.888 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.325672e-01 | 0.878 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.341145e-01 | 0.873 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.325672e-01 | 0.878 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.457518e-01 | 0.836 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.564582e-01 | 0.806 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.238349e-01 | 0.907 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.570587e-01 | 0.804 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.309744e-01 | 0.883 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.341145e-01 | 0.873 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.203194e-01 | 0.920 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.503042e-01 | 0.823 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.254586e-01 | 0.901 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.589794e-01 | 0.799 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.192607e-01 | 0.924 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.343641e-01 | 0.872 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.503089e-01 | 0.823 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.631885e-01 | 0.787 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.655298e-01 | 0.781 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.655298e-01 | 0.781 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.655298e-01 | 0.781 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.662886e-01 | 0.779 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.662886e-01 | 0.779 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.665965e-01 | 0.778 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.665965e-01 | 0.778 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.667640e-01 | 0.778 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.667640e-01 | 0.778 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.667659e-01 | 0.778 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.667659e-01 | 0.778 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.685347e-01 | 0.773 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.697114e-01 | 0.770 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.883764e-01 | 0.540 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.883764e-01 | 0.540 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.883764e-01 | 0.540 | 0 | 0 |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | R-HSA-5619068 | 2.883764e-01 | 0.540 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.883764e-01 | 0.540 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.883764e-01 | 0.540 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.883764e-01 | 0.540 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.883764e-01 | 0.540 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.883764e-01 | 0.540 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.883764e-01 | 0.540 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.883764e-01 | 0.540 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.094420e-01 | 0.679 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.094420e-01 | 0.679 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.718038e-01 | 0.566 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.718038e-01 | 0.566 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.718038e-01 | 0.566 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.718038e-01 | 0.566 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.718038e-01 | 0.566 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.718038e-01 | 0.566 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.996996e-01 | 0.398 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.996996e-01 | 0.398 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.996996e-01 | 0.398 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.996996e-01 | 0.398 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.996996e-01 | 0.398 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.996996e-01 | 0.398 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.996996e-01 | 0.398 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.996996e-01 | 0.398 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.996996e-01 | 0.398 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.996996e-01 | 0.398 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.996996e-01 | 0.398 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.996996e-01 | 0.398 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.996996e-01 | 0.398 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.996996e-01 | 0.398 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.996996e-01 | 0.398 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.996996e-01 | 0.398 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.996996e-01 | 0.398 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.996996e-01 | 0.398 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.996996e-01 | 0.398 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.996996e-01 | 0.398 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.996996e-01 | 0.398 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.996996e-01 | 0.398 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.996996e-01 | 0.398 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.827920e-01 | 0.738 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.429965e-01 | 0.614 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.429965e-01 | 0.614 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.429965e-01 | 0.614 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.429965e-01 | 0.614 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.429965e-01 | 0.614 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.429965e-01 | 0.614 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.340049e-01 | 0.476 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.340049e-01 | 0.476 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.340049e-01 | 0.476 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.340049e-01 | 0.476 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 3.340049e-01 | 0.476 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.340049e-01 | 0.476 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.951128e-01 | 0.710 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.884500e-01 | 0.540 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.884500e-01 | 0.540 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.884500e-01 | 0.540 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.884500e-01 | 0.540 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 2.884500e-01 | 0.540 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.884500e-01 | 0.540 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.884500e-01 | 0.540 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.884500e-01 | 0.540 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.884500e-01 | 0.540 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.534179e-01 | 0.596 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.534179e-01 | 0.596 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.249841e-01 | 0.648 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.249841e-01 | 0.648 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.011723e-01 | 0.696 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.011723e-01 | 0.696 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.906185e-01 | 0.537 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.906185e-01 | 0.537 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.906185e-01 | 0.537 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.344535e-01 | 0.476 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.344535e-01 | 0.476 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.344535e-01 | 0.476 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.945702e-01 | 0.404 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.945702e-01 | 0.404 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.945702e-01 | 0.404 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.945702e-01 | 0.404 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.945702e-01 | 0.404 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.945702e-01 | 0.404 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.945702e-01 | 0.404 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.945702e-01 | 0.404 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.945702e-01 | 0.404 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.945702e-01 | 0.404 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.945702e-01 | 0.404 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.936133e-01 | 0.307 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.936133e-01 | 0.307 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.936133e-01 | 0.307 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.936133e-01 | 0.307 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.936133e-01 | 0.307 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.936133e-01 | 0.307 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.936133e-01 | 0.307 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.936133e-01 | 0.307 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.936133e-01 | 0.307 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.936133e-01 | 0.307 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.045005e-01 | 0.689 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.045005e-01 | 0.689 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.045005e-01 | 0.689 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.881517e-01 | 0.540 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.881517e-01 | 0.540 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.881517e-01 | 0.540 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.265725e-01 | 0.645 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.265725e-01 | 0.645 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.265725e-01 | 0.645 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.265725e-01 | 0.645 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.265725e-01 | 0.645 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.284793e-01 | 0.483 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.284793e-01 | 0.483 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.832629e-01 | 0.737 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.832629e-01 | 0.737 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.832629e-01 | 0.737 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.832629e-01 | 0.737 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.528690e-01 | 0.597 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.803115e-01 | 0.420 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.803115e-01 | 0.420 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.803115e-01 | 0.420 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.803115e-01 | 0.420 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.803115e-01 | 0.420 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.494521e-01 | 0.603 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.494521e-01 | 0.603 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.494521e-01 | 0.603 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.494521e-01 | 0.603 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.494521e-01 | 0.603 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.494521e-01 | 0.603 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.494521e-01 | 0.603 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.208752e-01 | 0.494 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.785974e-01 | 0.555 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.785974e-01 | 0.555 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.455098e-01 | 0.610 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.758664e-01 | 0.755 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.758664e-01 | 0.755 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.149921e-01 | 0.668 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.730296e-01 | 0.564 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.730296e-01 | 0.564 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.730296e-01 | 0.564 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.665886e-01 | 0.436 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.665886e-01 | 0.436 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 4.524898e-01 | 0.344 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.524898e-01 | 0.344 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.524898e-01 | 0.344 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 4.524898e-01 | 0.344 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.673284e-01 | 0.573 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.673284e-01 | 0.573 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.049397e-01 | 0.516 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.049397e-01 | 0.516 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.971915e-01 | 0.527 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.971915e-01 | 0.527 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.971915e-01 | 0.527 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.424257e-01 | 0.465 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.254403e-01 | 0.371 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.254403e-01 | 0.371 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.254403e-01 | 0.371 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.450019e-01 | 0.611 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.824924e-01 | 0.549 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.045731e-01 | 0.393 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.125413e-01 | 0.505 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.872337e-01 | 0.412 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.872337e-01 | 0.412 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.872337e-01 | 0.412 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.877890e-01 | 0.541 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.877890e-01 | 0.541 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.722186e-01 | 0.429 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.733166e-01 | 0.563 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.468059e-01 | 0.460 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.357496e-01 | 0.474 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.255236e-01 | 0.487 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.906870e-01 | 0.537 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.704974e-01 | 0.568 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.203682e-01 | 0.376 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.203682e-01 | 0.376 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 4.421020e-01 | 0.354 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 4.421020e-01 | 0.354 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.421020e-01 | 0.354 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 4.421020e-01 | 0.354 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.421020e-01 | 0.354 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.693646e-01 | 0.328 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.693646e-01 | 0.328 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.693646e-01 | 0.328 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.693646e-01 | 0.328 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.693646e-01 | 0.328 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.071094e-01 | 0.295 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 5.071094e-01 | 0.295 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.071094e-01 | 0.295 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.071094e-01 | 0.295 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.071094e-01 | 0.295 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.071094e-01 | 0.295 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.071094e-01 | 0.295 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.071094e-01 | 0.295 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.171827e-01 | 0.499 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.465104e-01 | 0.460 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.973764e-01 | 0.401 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.345965e-01 | 0.475 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.135208e-01 | 0.384 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.135208e-01 | 0.384 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.665730e-01 | 0.436 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.052175e-01 | 0.515 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.522179e-01 | 0.453 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.531730e-01 | 0.344 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.531730e-01 | 0.344 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.066626e-01 | 0.391 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.697831e-01 | 0.569 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.227430e-01 | 0.374 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.227430e-01 | 0.374 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.227430e-01 | 0.374 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.788885e-01 | 0.320 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.145586e-01 | 0.382 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.145586e-01 | 0.382 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.070902e-01 | 0.390 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.117101e-01 | 0.291 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.117101e-01 | 0.291 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.117101e-01 | 0.291 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.117101e-01 | 0.291 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.117101e-01 | 0.291 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.369916e-01 | 0.360 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.854518e-01 | 0.314 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.854518e-01 | 0.314 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.274332e-01 | 0.369 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.945206e-01 | 0.306 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.595431e-01 | 0.338 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.030416e-01 | 0.692 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.417276e-01 | 0.355 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.758664e-01 | 0.755 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.522843e-01 | 0.345 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.135208e-01 | 0.384 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.981212e-01 | 0.703 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.729496e-01 | 0.762 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.195739e-01 | 0.658 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.759413e-01 | 0.559 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.759413e-01 | 0.559 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.191729e-01 | 0.659 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.729496e-01 | 0.762 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.832629e-01 | 0.737 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.367144e-01 | 0.473 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.872337e-01 | 0.412 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.468059e-01 | 0.460 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.455098e-01 | 0.610 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.363666e-01 | 0.473 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.000153e-01 | 0.523 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.592341e-01 | 0.445 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.731240e-01 | 0.325 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.560932e-01 | 0.592 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.647748e-01 | 0.577 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.827920e-01 | 0.738 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.553464e-01 | 0.593 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.531730e-01 | 0.344 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.284359e-01 | 0.484 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.070902e-01 | 0.390 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.560932e-01 | 0.592 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.429965e-01 | 0.614 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.344535e-01 | 0.476 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 4.788885e-01 | 0.320 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.117101e-01 | 0.291 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.625147e-01 | 0.581 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.116282e-01 | 0.674 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.746680e-01 | 0.758 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.000153e-01 | 0.523 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.935897e-01 | 0.307 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.693646e-01 | 0.328 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.788885e-01 | 0.320 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.563777e-01 | 0.341 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.801133e-01 | 0.744 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.801133e-01 | 0.744 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.755586e-01 | 0.560 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.827920e-01 | 0.738 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.534179e-01 | 0.596 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.897031e-01 | 0.538 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.045731e-01 | 0.393 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.613561e-01 | 0.336 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.864029e-01 | 0.730 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.569026e-01 | 0.447 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.284793e-01 | 0.483 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.045731e-01 | 0.393 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.514438e-01 | 0.454 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.731240e-01 | 0.325 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.565204e-01 | 0.341 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.803115e-01 | 0.420 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.479771e-01 | 0.606 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.255236e-01 | 0.487 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.477600e-01 | 0.349 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.592341e-01 | 0.445 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.475270e-01 | 0.459 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.171827e-01 | 0.499 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.718038e-01 | 0.566 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.429965e-01 | 0.614 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.945702e-01 | 0.404 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.803115e-01 | 0.420 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.412764e-01 | 0.617 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.071094e-01 | 0.295 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.071094e-01 | 0.295 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.829020e-01 | 0.417 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.078752e-01 | 0.682 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.066626e-01 | 0.391 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.066626e-01 | 0.391 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 3.125413e-01 | 0.505 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.045005e-01 | 0.689 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.243371e-01 | 0.649 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.718038e-01 | 0.566 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.340049e-01 | 0.476 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.884500e-01 | 0.540 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.884500e-01 | 0.540 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.344535e-01 | 0.476 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.424257e-01 | 0.465 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.850061e-01 | 0.733 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.861785e-01 | 0.413 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.693646e-01 | 0.328 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 4.788885e-01 | 0.320 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.117101e-01 | 0.291 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.480248e-01 | 0.349 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.207849e-01 | 0.494 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.468059e-01 | 0.460 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.078836e-01 | 0.512 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.842692e-01 | 0.735 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.203682e-01 | 0.376 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.049397e-01 | 0.516 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.006076e-01 | 0.698 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.122196e-01 | 0.506 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.827920e-01 | 0.738 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.117101e-01 | 0.291 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.805726e-01 | 0.318 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.221781e-01 | 0.375 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.310680e-01 | 0.480 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.049397e-01 | 0.516 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.921208e-01 | 0.407 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.921208e-01 | 0.407 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.009293e-01 | 0.300 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.722186e-01 | 0.429 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.592341e-01 | 0.445 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.576811e-01 | 0.447 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.444459e-01 | 0.612 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.239939e-01 | 0.373 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 2.149921e-01 | 0.668 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 2.149921e-01 | 0.668 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.421611e-01 | 0.466 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.407718e-01 | 0.356 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.613363e-01 | 0.336 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.008150e-01 | 0.397 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.024665e-01 | 0.694 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.660257e-01 | 0.575 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.468662e-01 | 0.608 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.094420e-01 | 0.679 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.340049e-01 | 0.476 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.340049e-01 | 0.476 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.344535e-01 | 0.476 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.936133e-01 | 0.307 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.665886e-01 | 0.436 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.673284e-01 | 0.573 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.391120e-01 | 0.621 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.468059e-01 | 0.460 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.693646e-01 | 0.328 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 5.071094e-01 | 0.295 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.318492e-01 | 0.365 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.788885e-01 | 0.320 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.776389e-01 | 0.321 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.945206e-01 | 0.306 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.031827e-01 | 0.394 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.837922e-01 | 0.736 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.714035e-01 | 0.566 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.841402e-01 | 0.315 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.255236e-01 | 0.487 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.894020e-01 | 0.538 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.777025e-01 | 0.750 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.494521e-01 | 0.603 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.730296e-01 | 0.564 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.745227e-01 | 0.324 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.138865e-01 | 0.670 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.103310e-01 | 0.508 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.243371e-01 | 0.649 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.788885e-01 | 0.320 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.254403e-01 | 0.371 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.424257e-01 | 0.465 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.613561e-01 | 0.336 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.835669e-01 | 0.316 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.460212e-01 | 0.609 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 4.904594e-01 | 0.309 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.309810e-01 | 0.366 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.832629e-01 | 0.737 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.227430e-01 | 0.374 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.249841e-01 | 0.648 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.945702e-01 | 0.404 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.083809e-01 | 0.511 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.421020e-01 | 0.354 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.541133e-01 | 0.343 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.560932e-01 | 0.592 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.128877e-01 | 0.505 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.421005e-01 | 0.466 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.705389e-01 | 0.431 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.864029e-01 | 0.730 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.534179e-01 | 0.596 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.249841e-01 | 0.648 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.524898e-01 | 0.344 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.038194e-01 | 0.517 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.731240e-01 | 0.325 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.504262e-01 | 0.601 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.066626e-01 | 0.391 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 3.938502e-01 | 0.405 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.304278e-01 | 0.366 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.045731e-01 | 0.393 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.115879e-01 | 0.506 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.328103e-01 | 0.364 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.328103e-01 | 0.364 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.141144e-01 | 0.669 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.078752e-01 | 0.682 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.465104e-01 | 0.460 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.744597e-01 | 0.427 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.252864e-01 | 0.647 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.718038e-01 | 0.566 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.996996e-01 | 0.398 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.429965e-01 | 0.614 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.340049e-01 | 0.476 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.884500e-01 | 0.540 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 2.884500e-01 | 0.540 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.344535e-01 | 0.476 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.945702e-01 | 0.404 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.945702e-01 | 0.404 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.936133e-01 | 0.307 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.936133e-01 | 0.307 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.539891e-01 | 0.451 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.254403e-01 | 0.371 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.125413e-01 | 0.505 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.443805e-01 | 0.612 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.203682e-01 | 0.376 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.788284e-01 | 0.422 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.066626e-01 | 0.391 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.775415e-01 | 0.557 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.788885e-01 | 0.320 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.613561e-01 | 0.336 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.837956e-01 | 0.547 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.750348e-01 | 0.323 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.159945e-01 | 0.500 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.735091e-01 | 0.761 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.808239e-01 | 0.743 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.421005e-01 | 0.466 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.904594e-01 | 0.309 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.344535e-01 | 0.476 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.171827e-01 | 0.499 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.788885e-01 | 0.320 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.227430e-01 | 0.374 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.401350e-01 | 0.620 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 2.173208e-01 | 0.663 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.945702e-01 | 0.404 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.665886e-01 | 0.436 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.722186e-01 | 0.429 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.720279e-01 | 0.429 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.071094e-01 | 0.295 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.117101e-01 | 0.291 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.117101e-01 | 0.291 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.117101e-01 | 0.291 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 4.001913e-01 | 0.398 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.213426e-01 | 0.655 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.163135e-01 | 0.500 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.159945e-01 | 0.500 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.829020e-01 | 0.417 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.429965e-01 | 0.614 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.906185e-01 | 0.537 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.344535e-01 | 0.476 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.986465e-01 | 0.525 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.409381e-01 | 0.618 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.328103e-01 | 0.364 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.011723e-01 | 0.696 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.843117e-01 | 0.546 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.627153e-01 | 0.581 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.906185e-01 | 0.537 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.292240e-01 | 0.483 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.936133e-01 | 0.307 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.254403e-01 | 0.371 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.045731e-01 | 0.393 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.117101e-01 | 0.291 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.854518e-01 | 0.314 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.850387e-01 | 0.314 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.259349e-01 | 0.646 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.049397e-01 | 0.516 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.277395e-01 | 0.643 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.945702e-01 | 0.404 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.779213e-01 | 0.556 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.973764e-01 | 0.401 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 2.718038e-01 | 0.566 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.936133e-01 | 0.307 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 4.421020e-01 | 0.354 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 5.071094e-01 | 0.295 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.071094e-01 | 0.295 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.758664e-01 | 0.755 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.318492e-01 | 0.365 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 3.340049e-01 | 0.476 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 4.524898e-01 | 0.344 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.071094e-01 | 0.295 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.553189e-01 | 0.449 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.010502e-01 | 0.300 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.532939e-01 | 0.344 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.537371e-01 | 0.343 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.146901e-01 | 0.288 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.146901e-01 | 0.288 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.146901e-01 | 0.288 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.146901e-01 | 0.288 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.146901e-01 | 0.288 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.170322e-01 | 0.286 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.170322e-01 | 0.286 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.170322e-01 | 0.286 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.190285e-01 | 0.285 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.200250e-01 | 0.284 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.208025e-01 | 0.283 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.208025e-01 | 0.283 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.208025e-01 | 0.283 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.212047e-01 | 0.283 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.224185e-01 | 0.282 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.266372e-01 | 0.278 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.278936e-01 | 0.277 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.302444e-01 | 0.276 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.313519e-01 | 0.275 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.322978e-01 | 0.274 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.373041e-01 | 0.270 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.462732e-01 | 0.263 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.464531e-01 | 0.262 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.465296e-01 | 0.262 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.465296e-01 | 0.262 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.465296e-01 | 0.262 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.465296e-01 | 0.262 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.465625e-01 | 0.262 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.467356e-01 | 0.262 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.487588e-01 | 0.261 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.493070e-01 | 0.260 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.493070e-01 | 0.260 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.493070e-01 | 0.260 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.493070e-01 | 0.260 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.503226e-01 | 0.259 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.521937e-01 | 0.258 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.521937e-01 | 0.258 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.521937e-01 | 0.258 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.521937e-01 | 0.258 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.521937e-01 | 0.258 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.553468e-01 | 0.255 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 5.580441e-01 | 0.253 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 5.580441e-01 | 0.253 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.580441e-01 | 0.253 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.580441e-01 | 0.253 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.580441e-01 | 0.253 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 5.580441e-01 | 0.253 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.580441e-01 | 0.253 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.580441e-01 | 0.253 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.580441e-01 | 0.253 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 5.580441e-01 | 0.253 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 5.580441e-01 | 0.253 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.580441e-01 | 0.253 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 5.580441e-01 | 0.253 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.597665e-01 | 0.252 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.660636e-01 | 0.247 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.660636e-01 | 0.247 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.687161e-01 | 0.245 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.687161e-01 | 0.245 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.699851e-01 | 0.244 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.699851e-01 | 0.244 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.728392e-01 | 0.242 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.728392e-01 | 0.242 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.728392e-01 | 0.242 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.728392e-01 | 0.242 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.728392e-01 | 0.242 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.728392e-01 | 0.242 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.728392e-01 | 0.242 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.728392e-01 | 0.242 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.728392e-01 | 0.242 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.728392e-01 | 0.242 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.728392e-01 | 0.242 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.728392e-01 | 0.242 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.728392e-01 | 0.242 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.728392e-01 | 0.242 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.728392e-01 | 0.242 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.728392e-01 | 0.242 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.728392e-01 | 0.242 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.728392e-01 | 0.242 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.738245e-01 | 0.241 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.775281e-01 | 0.238 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.815512e-01 | 0.235 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.818605e-01 | 0.235 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.825802e-01 | 0.235 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.825802e-01 | 0.235 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.825802e-01 | 0.235 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.835817e-01 | 0.234 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.844426e-01 | 0.233 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.868028e-01 | 0.232 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.904211e-01 | 0.229 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.904211e-01 | 0.229 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.906129e-01 | 0.229 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.906129e-01 | 0.229 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.906129e-01 | 0.229 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.906129e-01 | 0.229 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.906129e-01 | 0.229 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.906129e-01 | 0.229 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.906129e-01 | 0.229 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.929531e-01 | 0.227 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.960996e-01 | 0.225 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.960996e-01 | 0.225 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.961989e-01 | 0.225 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.961989e-01 | 0.225 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.961989e-01 | 0.225 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.995458e-01 | 0.222 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.004551e-01 | 0.222 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.004551e-01 | 0.222 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.008015e-01 | 0.221 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.051100e-01 | 0.218 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.051100e-01 | 0.218 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.051100e-01 | 0.218 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.051100e-01 | 0.218 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.051100e-01 | 0.218 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.051100e-01 | 0.218 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.051100e-01 | 0.218 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.051100e-01 | 0.218 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 6.051100e-01 | 0.218 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.062171e-01 | 0.217 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.062171e-01 | 0.217 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.082980e-01 | 0.216 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.142940e-01 | 0.212 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.153040e-01 | 0.211 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.197575e-01 | 0.208 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.199426e-01 | 0.208 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.199426e-01 | 0.208 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.208667e-01 | 0.207 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.268347e-01 | 0.203 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.268347e-01 | 0.203 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.268347e-01 | 0.203 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.268347e-01 | 0.203 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.268347e-01 | 0.203 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.268347e-01 | 0.203 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.268347e-01 | 0.203 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.268347e-01 | 0.203 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.268347e-01 | 0.203 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.282548e-01 | 0.202 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.282548e-01 | 0.202 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.318278e-01 | 0.199 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.322049e-01 | 0.199 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.337525e-01 | 0.198 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.337525e-01 | 0.198 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.342480e-01 | 0.198 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.350471e-01 | 0.197 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.363417e-01 | 0.196 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 6.396737e-01 | 0.194 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.396737e-01 | 0.194 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 6.396737e-01 | 0.194 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 6.396737e-01 | 0.194 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.396737e-01 | 0.194 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 6.396737e-01 | 0.194 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 6.396737e-01 | 0.194 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 6.396737e-01 | 0.194 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 6.396737e-01 | 0.194 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 6.396737e-01 | 0.194 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 6.396737e-01 | 0.194 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.398567e-01 | 0.194 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.428986e-01 | 0.192 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.433323e-01 | 0.192 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.441571e-01 | 0.191 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.446426e-01 | 0.191 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.446426e-01 | 0.191 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.446426e-01 | 0.191 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 6.446426e-01 | 0.191 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.473977e-01 | 0.189 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.482709e-01 | 0.188 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 6.482709e-01 | 0.188 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 6.482709e-01 | 0.188 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.482709e-01 | 0.188 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 6.482709e-01 | 0.188 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.482709e-01 | 0.188 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 6.482709e-01 | 0.188 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 6.482709e-01 | 0.188 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.522077e-01 | 0.186 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.579788e-01 | 0.182 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.579788e-01 | 0.182 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.600740e-01 | 0.180 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.600740e-01 | 0.180 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.600740e-01 | 0.180 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.607849e-01 | 0.180 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.607849e-01 | 0.180 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.607849e-01 | 0.180 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.612214e-01 | 0.180 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.668821e-01 | 0.176 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.682078e-01 | 0.175 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.682078e-01 | 0.175 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.715765e-01 | 0.173 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.732873e-01 | 0.172 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.732873e-01 | 0.172 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.732873e-01 | 0.172 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.738245e-01 | 0.171 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 6.738245e-01 | 0.171 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.782334e-01 | 0.169 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.782334e-01 | 0.169 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.793932e-01 | 0.168 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.817298e-01 | 0.166 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.839906e-01 | 0.165 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.851398e-01 | 0.164 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.851398e-01 | 0.164 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.851398e-01 | 0.164 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.862916e-01 | 0.163 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.862916e-01 | 0.163 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.875965e-01 | 0.163 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.875965e-01 | 0.163 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 6.875965e-01 | 0.163 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 6.875965e-01 | 0.163 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.875965e-01 | 0.163 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.875965e-01 | 0.163 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 6.875965e-01 | 0.163 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.875965e-01 | 0.163 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.902340e-01 | 0.161 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.902877e-01 | 0.161 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.902877e-01 | 0.161 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.902877e-01 | 0.161 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.924383e-01 | 0.160 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.924383e-01 | 0.160 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.924383e-01 | 0.160 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.926318e-01 | 0.159 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.960544e-01 | 0.157 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.960544e-01 | 0.157 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.960544e-01 | 0.157 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.960544e-01 | 0.157 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.960544e-01 | 0.157 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.960544e-01 | 0.157 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.960544e-01 | 0.157 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.960544e-01 | 0.157 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.960544e-01 | 0.157 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.960544e-01 | 0.157 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.960544e-01 | 0.157 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.960544e-01 | 0.157 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.960544e-01 | 0.157 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.960544e-01 | 0.157 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.960544e-01 | 0.157 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.960544e-01 | 0.157 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.960544e-01 | 0.157 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.960544e-01 | 0.157 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.962560e-01 | 0.157 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.962560e-01 | 0.157 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.962560e-01 | 0.157 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.977315e-01 | 0.156 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.002916e-01 | 0.155 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.002916e-01 | 0.155 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.002916e-01 | 0.155 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.002916e-01 | 0.155 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.010524e-01 | 0.154 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.013989e-01 | 0.154 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.060529e-01 | 0.151 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.066732e-01 | 0.151 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.066732e-01 | 0.151 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.083223e-01 | 0.150 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.089244e-01 | 0.149 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.089244e-01 | 0.149 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.089244e-01 | 0.149 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.164553e-01 | 0.145 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.176324e-01 | 0.144 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.176324e-01 | 0.144 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.176324e-01 | 0.144 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.181942e-01 | 0.144 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.181942e-01 | 0.144 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.181942e-01 | 0.144 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.181942e-01 | 0.144 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.181942e-01 | 0.144 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.213631e-01 | 0.142 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.218098e-01 | 0.142 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.218098e-01 | 0.142 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.218098e-01 | 0.142 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.218098e-01 | 0.142 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.218098e-01 | 0.142 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.232301e-01 | 0.141 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.232301e-01 | 0.141 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.232301e-01 | 0.141 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.232301e-01 | 0.141 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.232301e-01 | 0.141 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.232301e-01 | 0.141 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.232301e-01 | 0.141 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.256482e-01 | 0.139 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.256669e-01 | 0.139 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.304192e-01 | 0.136 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.314175e-01 | 0.136 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.314175e-01 | 0.136 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.341262e-01 | 0.134 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.343662e-01 | 0.134 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.343930e-01 | 0.134 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.379440e-01 | 0.132 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 7.379440e-01 | 0.132 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.394317e-01 | 0.131 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 7.436158e-01 | 0.129 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.436158e-01 | 0.129 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.436158e-01 | 0.129 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.436158e-01 | 0.129 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.436158e-01 | 0.129 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.436158e-01 | 0.129 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 7.436158e-01 | 0.129 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.436158e-01 | 0.129 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 7.436158e-01 | 0.129 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 7.436158e-01 | 0.129 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 7.436158e-01 | 0.129 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 7.436158e-01 | 0.129 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 7.436158e-01 | 0.129 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 7.436158e-01 | 0.129 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 7.436158e-01 | 0.129 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 7.436158e-01 | 0.129 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 7.436158e-01 | 0.129 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 7.436158e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 7.436158e-01 | 0.129 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 7.436158e-01 | 0.129 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 7.436158e-01 | 0.129 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.447526e-01 | 0.128 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.465835e-01 | 0.127 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.465835e-01 | 0.127 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.465835e-01 | 0.127 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.489455e-01 | 0.126 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.489455e-01 | 0.126 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.489455e-01 | 0.126 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.489455e-01 | 0.126 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.493696e-01 | 0.125 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.493696e-01 | 0.125 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.493696e-01 | 0.125 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.504245e-01 | 0.125 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.509321e-01 | 0.124 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.526213e-01 | 0.123 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.526213e-01 | 0.123 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.540581e-01 | 0.123 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.553642e-01 | 0.122 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.553642e-01 | 0.122 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.553642e-01 | 0.122 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.553642e-01 | 0.122 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.553642e-01 | 0.122 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 7.553642e-01 | 0.122 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.571904e-01 | 0.121 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.641654e-01 | 0.117 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.681293e-01 | 0.115 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.714846e-01 | 0.113 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.714846e-01 | 0.113 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.714846e-01 | 0.113 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.725498e-01 | 0.112 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.725498e-01 | 0.112 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.725498e-01 | 0.112 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.739164e-01 | 0.111 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.790898e-01 | 0.108 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.791562e-01 | 0.108 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.791562e-01 | 0.108 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 7.837372e-01 | 0.106 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.837372e-01 | 0.106 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.837372e-01 | 0.106 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.837372e-01 | 0.106 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.837372e-01 | 0.106 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.837372e-01 | 0.106 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.837372e-01 | 0.106 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.837372e-01 | 0.106 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.837372e-01 | 0.106 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.837372e-01 | 0.106 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.837372e-01 | 0.106 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 7.837372e-01 | 0.106 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.842213e-01 | 0.106 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 7.842213e-01 | 0.106 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.842213e-01 | 0.106 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.842213e-01 | 0.106 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 7.842213e-01 | 0.106 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 7.842213e-01 | 0.106 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 7.842213e-01 | 0.106 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.842213e-01 | 0.106 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.842213e-01 | 0.106 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 7.842213e-01 | 0.106 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.842213e-01 | 0.106 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.860394e-01 | 0.105 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.912260e-01 | 0.102 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.920353e-01 | 0.101 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.920353e-01 | 0.101 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.925244e-01 | 0.101 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.925244e-01 | 0.101 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.927327e-01 | 0.101 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.950237e-01 | 0.100 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.950237e-01 | 0.100 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.950237e-01 | 0.100 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.950773e-01 | 0.100 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.968118e-01 | 0.099 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.968118e-01 | 0.099 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 7.968118e-01 | 0.099 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.968118e-01 | 0.099 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.968118e-01 | 0.099 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 7.982332e-01 | 0.098 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.982332e-01 | 0.098 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.005557e-01 | 0.097 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.015710e-01 | 0.096 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.018670e-01 | 0.096 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.022179e-01 | 0.096 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.055978e-01 | 0.094 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.086473e-01 | 0.092 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.086473e-01 | 0.092 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.086473e-01 | 0.092 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.086814e-01 | 0.092 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.090656e-01 | 0.092 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.100122e-01 | 0.092 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.100400e-01 | 0.091 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.100400e-01 | 0.091 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.100400e-01 | 0.091 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.100400e-01 | 0.091 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.100400e-01 | 0.091 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.110744e-01 | 0.091 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.110744e-01 | 0.091 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.110744e-01 | 0.091 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.122428e-01 | 0.090 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.169214e-01 | 0.088 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.175818e-01 | 0.087 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 8.175818e-01 | 0.087 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.175818e-01 | 0.087 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 8.175818e-01 | 0.087 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 8.175818e-01 | 0.087 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 8.175818e-01 | 0.087 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 8.175818e-01 | 0.087 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 8.175818e-01 | 0.087 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 8.175818e-01 | 0.087 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 8.175818e-01 | 0.087 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 8.175818e-01 | 0.087 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 8.175818e-01 | 0.087 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 8.175818e-01 | 0.087 | 0 | 0 |
| Biosynthesis of maresin conjugates in tissue regeneration (MCTR) | R-HSA-9026762 | 8.175818e-01 | 0.087 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 8.175818e-01 | 0.087 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.177340e-01 | 0.087 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.220322e-01 | 0.085 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.237735e-01 | 0.084 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.245657e-01 | 0.084 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.249538e-01 | 0.084 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.249538e-01 | 0.084 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.249538e-01 | 0.084 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.260700e-01 | 0.083 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.271873e-01 | 0.082 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.271873e-01 | 0.082 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.275022e-01 | 0.082 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.286629e-01 | 0.082 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.286629e-01 | 0.082 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.330644e-01 | 0.079 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.330644e-01 | 0.079 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.330644e-01 | 0.079 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.330644e-01 | 0.079 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.330644e-01 | 0.079 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.330644e-01 | 0.079 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.330644e-01 | 0.079 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.331222e-01 | 0.079 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.367941e-01 | 0.077 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.367941e-01 | 0.077 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.374309e-01 | 0.077 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.379331e-01 | 0.077 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.379331e-01 | 0.077 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.379331e-01 | 0.077 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.379331e-01 | 0.077 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.379331e-01 | 0.077 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.379331e-01 | 0.077 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.379331e-01 | 0.077 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.448677e-01 | 0.073 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.448677e-01 | 0.073 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.457048e-01 | 0.073 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 8.461315e-01 | 0.073 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.461315e-01 | 0.073 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.461315e-01 | 0.073 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 8.461315e-01 | 0.073 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 8.461315e-01 | 0.073 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 8.461315e-01 | 0.073 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 8.461315e-01 | 0.073 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.464525e-01 | 0.072 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.511594e-01 | 0.070 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.511594e-01 | 0.070 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.511594e-01 | 0.070 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.533994e-01 | 0.069 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.535365e-01 | 0.069 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.535365e-01 | 0.069 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.535365e-01 | 0.069 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.535365e-01 | 0.069 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.535365e-01 | 0.069 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.541081e-01 | 0.068 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.541081e-01 | 0.068 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.541081e-01 | 0.068 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.541081e-01 | 0.068 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.541257e-01 | 0.068 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.541257e-01 | 0.068 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.541257e-01 | 0.068 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.574702e-01 | 0.067 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.574702e-01 | 0.067 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.597598e-01 | 0.066 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.597598e-01 | 0.066 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.617979e-01 | 0.065 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.634887e-01 | 0.064 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.634887e-01 | 0.064 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.634887e-01 | 0.064 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.645838e-01 | 0.063 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.671223e-01 | 0.062 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.671223e-01 | 0.062 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.671223e-01 | 0.062 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.697942e-01 | 0.061 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.697942e-01 | 0.061 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.697942e-01 | 0.061 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.697942e-01 | 0.061 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.702144e-01 | 0.060 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.702144e-01 | 0.060 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.702144e-01 | 0.060 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.702144e-01 | 0.060 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.702144e-01 | 0.060 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 8.702144e-01 | 0.060 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.702144e-01 | 0.060 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.702144e-01 | 0.060 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 8.702144e-01 | 0.060 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.702144e-01 | 0.060 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 8.702144e-01 | 0.060 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.702144e-01 | 0.060 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.702144e-01 | 0.060 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.712940e-01 | 0.060 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.713340e-01 | 0.060 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.716913e-01 | 0.060 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.716913e-01 | 0.060 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.716913e-01 | 0.060 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.716913e-01 | 0.060 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.716913e-01 | 0.060 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.716913e-01 | 0.060 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.716913e-01 | 0.060 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.725387e-01 | 0.059 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.734130e-01 | 0.059 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.734130e-01 | 0.059 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.734130e-01 | 0.059 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.758598e-01 | 0.058 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.761207e-01 | 0.057 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.778417e-01 | 0.057 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.791278e-01 | 0.056 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.806467e-01 | 0.055 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.827510e-01 | 0.054 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.837158e-01 | 0.054 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.839704e-01 | 0.054 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.839704e-01 | 0.054 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.839704e-01 | 0.054 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.839704e-01 | 0.054 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.844821e-01 | 0.053 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.856105e-01 | 0.053 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.856105e-01 | 0.053 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.859019e-01 | 0.053 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.877525e-01 | 0.052 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.877525e-01 | 0.052 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.896364e-01 | 0.051 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.896364e-01 | 0.051 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.896364e-01 | 0.051 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.901954e-01 | 0.051 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.902366e-01 | 0.050 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.905290e-01 | 0.050 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.905290e-01 | 0.050 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.905290e-01 | 0.050 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.905290e-01 | 0.050 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.905290e-01 | 0.050 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.905290e-01 | 0.050 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.905290e-01 | 0.050 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.905290e-01 | 0.050 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.905290e-01 | 0.050 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.905290e-01 | 0.050 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.905290e-01 | 0.050 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.905290e-01 | 0.050 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.905290e-01 | 0.050 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.905290e-01 | 0.050 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.905290e-01 | 0.050 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.905290e-01 | 0.050 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.962696e-01 | 0.048 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.966553e-01 | 0.047 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.967525e-01 | 0.047 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.967525e-01 | 0.047 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.982349e-01 | 0.047 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.003785e-01 | 0.046 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.003785e-01 | 0.046 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.003785e-01 | 0.046 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.011289e-01 | 0.045 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.019305e-01 | 0.045 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.019305e-01 | 0.045 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.019305e-01 | 0.045 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.019305e-01 | 0.045 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.036371e-01 | 0.044 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.049707e-01 | 0.043 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.068145e-01 | 0.042 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.068145e-01 | 0.042 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.068145e-01 | 0.042 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 9.076649e-01 | 0.042 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 9.076649e-01 | 0.042 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 9.076649e-01 | 0.042 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 9.076649e-01 | 0.042 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 9.076649e-01 | 0.042 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 9.076649e-01 | 0.042 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 9.076649e-01 | 0.042 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 9.076649e-01 | 0.042 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 9.076649e-01 | 0.042 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 9.076649e-01 | 0.042 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 9.076649e-01 | 0.042 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.076854e-01 | 0.042 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.076854e-01 | 0.042 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.076854e-01 | 0.042 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.082525e-01 | 0.042 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.082525e-01 | 0.042 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.093595e-01 | 0.041 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.093595e-01 | 0.041 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.097303e-01 | 0.041 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.097303e-01 | 0.041 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.097303e-01 | 0.041 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.144213e-01 | 0.039 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.144213e-01 | 0.039 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.144213e-01 | 0.039 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.156856e-01 | 0.038 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.161459e-01 | 0.038 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.170462e-01 | 0.038 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.171260e-01 | 0.038 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.171260e-01 | 0.038 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.171260e-01 | 0.038 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.185782e-01 | 0.037 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.185782e-01 | 0.037 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.208362e-01 | 0.036 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.208362e-01 | 0.036 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 9.221193e-01 | 0.035 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 9.221193e-01 | 0.035 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 9.221193e-01 | 0.035 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 9.221193e-01 | 0.035 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.222245e-01 | 0.035 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.254057e-01 | 0.034 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.254057e-01 | 0.034 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.254057e-01 | 0.034 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.254057e-01 | 0.034 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.254057e-01 | 0.034 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.254057e-01 | 0.034 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.256931e-01 | 0.034 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.276384e-01 | 0.033 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.278318e-01 | 0.033 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.278318e-01 | 0.033 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.302318e-01 | 0.031 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.333178e-01 | 0.030 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 9.343116e-01 | 0.030 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 9.343116e-01 | 0.030 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.343116e-01 | 0.030 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.343116e-01 | 0.030 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 9.343116e-01 | 0.030 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 9.343116e-01 | 0.030 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.343116e-01 | 0.030 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 9.343116e-01 | 0.030 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 9.343116e-01 | 0.030 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.345286e-01 | 0.029 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.345867e-01 | 0.029 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.350490e-01 | 0.029 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.350490e-01 | 0.029 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.350490e-01 | 0.029 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.350490e-01 | 0.029 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.356547e-01 | 0.029 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.361097e-01 | 0.029 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.362198e-01 | 0.029 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.364573e-01 | 0.029 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.396236e-01 | 0.027 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.406742e-01 | 0.027 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.422243e-01 | 0.026 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.422243e-01 | 0.026 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.435019e-01 | 0.025 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.435019e-01 | 0.025 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.445958e-01 | 0.025 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.445958e-01 | 0.025 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.445958e-01 | 0.025 | 0 | 0 |
| Interconversion of polyamines | R-HSA-351200 | 9.445958e-01 | 0.025 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.445958e-01 | 0.025 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.445958e-01 | 0.025 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.445958e-01 | 0.025 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.445958e-01 | 0.025 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.500938e-01 | 0.022 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.503699e-01 | 0.022 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.509007e-01 | 0.022 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.509007e-01 | 0.022 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.509007e-01 | 0.022 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.509007e-01 | 0.022 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.509007e-01 | 0.022 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.512304e-01 | 0.022 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.525236e-01 | 0.021 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.532704e-01 | 0.021 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.532704e-01 | 0.021 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.532704e-01 | 0.021 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.532704e-01 | 0.021 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 9.532704e-01 | 0.021 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.532704e-01 | 0.021 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.532704e-01 | 0.021 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.532704e-01 | 0.021 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.532704e-01 | 0.021 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.532704e-01 | 0.021 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.532704e-01 | 0.021 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.532704e-01 | 0.021 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.568969e-01 | 0.019 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.573682e-01 | 0.019 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.573682e-01 | 0.019 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.573682e-01 | 0.019 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.573682e-01 | 0.019 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.588287e-01 | 0.018 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.605873e-01 | 0.017 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.605873e-01 | 0.017 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.605873e-01 | 0.017 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.605873e-01 | 0.017 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.605873e-01 | 0.017 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.605873e-01 | 0.017 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.605873e-01 | 0.017 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 9.605873e-01 | 0.017 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.605873e-01 | 0.017 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 9.605873e-01 | 0.017 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.605873e-01 | 0.017 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.630146e-01 | 0.016 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.630146e-01 | 0.016 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.646034e-01 | 0.016 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.667588e-01 | 0.015 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.667588e-01 | 0.015 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.667588e-01 | 0.015 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.667588e-01 | 0.015 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.667588e-01 | 0.015 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.667588e-01 | 0.015 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.667588e-01 | 0.015 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.667588e-01 | 0.015 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.674991e-01 | 0.014 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.679384e-01 | 0.014 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.679384e-01 | 0.014 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.679384e-01 | 0.014 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.686863e-01 | 0.014 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.699169e-01 | 0.013 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.699169e-01 | 0.013 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.701645e-01 | 0.013 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.701645e-01 | 0.013 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.706983e-01 | 0.013 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.716156e-01 | 0.013 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.719642e-01 | 0.012 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.719642e-01 | 0.012 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.719642e-01 | 0.012 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.719642e-01 | 0.012 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 9.719642e-01 | 0.012 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.719642e-01 | 0.012 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.722275e-01 | 0.012 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.722275e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.735534e-01 | 0.012 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.736053e-01 | 0.012 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.759598e-01 | 0.011 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.759598e-01 | 0.011 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.759598e-01 | 0.011 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.763548e-01 | 0.010 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.763548e-01 | 0.010 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.763548e-01 | 0.010 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.763548e-01 | 0.010 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.763548e-01 | 0.010 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.763548e-01 | 0.010 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.763548e-01 | 0.010 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.764790e-01 | 0.010 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.767700e-01 | 0.010 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.767700e-01 | 0.010 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.772855e-01 | 0.010 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.792045e-01 | 0.009 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.796119e-01 | 0.009 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.800579e-01 | 0.009 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.800579e-01 | 0.009 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.800579e-01 | 0.009 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.800579e-01 | 0.009 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.800579e-01 | 0.009 | 0 | 0 |
| Biosynthesis of DHA-derived sulfido conjugates | R-HSA-9026395 | 9.800579e-01 | 0.009 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.803896e-01 | 0.009 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.805678e-01 | 0.009 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.820227e-01 | 0.008 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.821201e-01 | 0.008 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.821201e-01 | 0.008 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.821528e-01 | 0.008 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.830163e-01 | 0.007 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.831813e-01 | 0.007 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.831813e-01 | 0.007 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.831813e-01 | 0.007 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.831813e-01 | 0.007 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.831813e-01 | 0.007 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.835957e-01 | 0.007 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.838396e-01 | 0.007 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.838815e-01 | 0.007 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.843315e-01 | 0.007 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.843315e-01 | 0.007 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.844685e-01 | 0.007 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.855265e-01 | 0.006 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.855265e-01 | 0.006 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.858157e-01 | 0.006 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.858157e-01 | 0.006 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.858157e-01 | 0.006 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.861356e-01 | 0.006 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.862794e-01 | 0.006 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.864134e-01 | 0.006 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.865894e-01 | 0.006 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.880375e-01 | 0.005 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.880375e-01 | 0.005 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.880375e-01 | 0.005 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.880375e-01 | 0.005 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.880375e-01 | 0.005 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.880375e-01 | 0.005 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.880375e-01 | 0.005 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.884270e-01 | 0.005 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.885819e-01 | 0.005 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.887580e-01 | 0.005 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.892359e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.895006e-01 | 0.005 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.898450e-01 | 0.004 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.899114e-01 | 0.004 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.899114e-01 | 0.004 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.899114e-01 | 0.004 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.901800e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.904908e-01 | 0.004 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.904908e-01 | 0.004 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.908245e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.911071e-01 | 0.004 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.912000e-01 | 0.004 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.913949e-01 | 0.004 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.914919e-01 | 0.004 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.914919e-01 | 0.004 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.914919e-01 | 0.004 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.914919e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.916885e-01 | 0.004 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.919368e-01 | 0.004 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.925853e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.925853e-01 | 0.003 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.925853e-01 | 0.003 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.925853e-01 | 0.003 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.925853e-01 | 0.003 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.928248e-01 | 0.003 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.928248e-01 | 0.003 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.928248e-01 | 0.003 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.930057e-01 | 0.003 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.932806e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.936141e-01 | 0.003 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.939490e-01 | 0.003 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.939490e-01 | 0.003 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.939490e-01 | 0.003 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.939490e-01 | 0.003 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.939490e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.942903e-01 | 0.002 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.948971e-01 | 0.002 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.948971e-01 | 0.002 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.948971e-01 | 0.002 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.948971e-01 | 0.002 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.948971e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.948971e-01 | 0.002 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.948971e-01 | 0.002 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.948971e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.949712e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.952694e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.952694e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.953451e-01 | 0.002 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.956967e-01 | 0.002 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.956967e-01 | 0.002 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.956967e-01 | 0.002 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.957205e-01 | 0.002 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.958107e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.959283e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.959310e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.963711e-01 | 0.002 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.963711e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.963711e-01 | 0.002 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.963711e-01 | 0.002 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.963711e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.963711e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.965015e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.965512e-01 | 0.002 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.969398e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.969436e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.969931e-01 | 0.001 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.971190e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.972327e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.973197e-01 | 0.001 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.974194e-01 | 0.001 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.974194e-01 | 0.001 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.974194e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.974194e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.974551e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.974751e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.975332e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.975734e-01 | 0.001 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.978238e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.978893e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.980950e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.981363e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.981649e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.983767e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.984109e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.984172e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.984876e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.985416e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.985972e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.986878e-01 | 0.001 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.986951e-01 | 0.001 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.986951e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.987511e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.987511e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.987929e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.988117e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.988620e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.988913e-01 | 0.000 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.988997e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.989080e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.989857e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.991155e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.991600e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.991662e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.991909e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.992177e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.992420e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.992595e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.992719e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.992719e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.993506e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.993506e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.993588e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.994224e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.994254e-01 | 0.000 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.994438e-01 | 0.000 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.994438e-01 | 0.000 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.994438e-01 | 0.000 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.994438e-01 | 0.000 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.995310e-01 | 0.000 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.996045e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.997212e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997317e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997411e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.997630e-01 | 0.000 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.997630e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.998315e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998384e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.998579e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.998708e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.998802e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.998833e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.998970e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.998990e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999042e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.999149e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.999149e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999185e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999272e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999308e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999340e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999472e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999543e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999552e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.999570e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.999613e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999670e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999713e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999713e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999785e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999795e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999795e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999817e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999848e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999851e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999858e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999890e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.999890e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999894e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999908e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999922e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999933e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999933e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999945e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999949e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999950e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999953e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999959e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999959e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999961e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999967e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999982e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999983e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999984e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999987e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999988e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999990e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999993e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999995e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999995e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999996e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999997e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999998e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 7.771561e-16 | 15.109 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.265654e-14 | 13.898 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.555178e-12 | 11.593 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.104916e-11 | 10.957 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.110245e-11 | 10.507 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.558864e-11 | 10.255 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.007721e-10 | 9.997 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.269854e-10 | 9.896 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.269854e-10 | 9.896 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.948959e-10 | 9.530 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.890114e-10 | 9.410 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.684101e-10 | 9.329 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.089300e-10 | 9.092 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.034191e-09 | 8.985 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.523303e-09 | 8.598 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.385456e-09 | 8.470 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.027634e-08 | 7.988 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.060239e-08 | 7.975 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.489203e-08 | 7.827 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.730978e-08 | 7.762 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.758134e-08 | 7.755 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.445332e-08 | 7.612 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.709354e-08 | 7.567 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.460795e-08 | 7.351 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.037542e-08 | 7.153 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.460762e-08 | 7.024 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.038730e-07 | 6.983 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.382398e-07 | 6.859 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.761447e-07 | 6.754 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.887111e-07 | 6.724 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.927768e-07 | 6.715 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.202327e-07 | 6.657 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.615438e-07 | 6.582 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.342746e-07 | 6.476 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.356738e-07 | 6.474 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.381717e-07 | 6.358 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.381717e-07 | 6.358 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.054028e-07 | 6.296 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.054028e-07 | 6.296 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.209588e-07 | 6.283 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.056837e-07 | 6.218 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.282419e-07 | 6.138 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.800061e-07 | 6.056 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.800061e-07 | 6.056 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.046522e-06 | 5.980 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.238769e-06 | 5.907 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.520337e-06 | 5.818 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.520337e-06 | 5.818 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.520337e-06 | 5.818 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.520337e-06 | 5.818 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.740253e-06 | 5.759 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.068541e-06 | 5.684 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.403294e-06 | 5.619 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.857418e-06 | 5.544 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.857418e-06 | 5.544 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.955491e-06 | 5.529 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.120819e-06 | 5.506 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.120819e-06 | 5.506 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.095438e-06 | 5.509 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.393593e-06 | 5.469 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.127651e-06 | 5.384 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.330834e-06 | 5.363 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.490135e-06 | 5.348 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.232000e-06 | 5.281 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.383167e-06 | 5.269 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.023282e-06 | 5.220 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.054165e-06 | 5.218 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.934395e-06 | 5.159 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.266581e-06 | 5.083 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.632479e-06 | 5.064 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.780080e-06 | 5.057 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.916785e-06 | 5.050 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.234641e-06 | 5.035 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.032596e-05 | 4.986 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.325401e-05 | 4.878 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.885121e-05 | 4.725 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.920900e-05 | 4.716 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.960052e-05 | 4.708 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.009459e-05 | 4.697 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.120015e-05 | 4.674 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.753024e-05 | 4.560 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.898875e-05 | 4.538 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.130595e-05 | 4.504 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.371465e-05 | 4.472 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.552385e-05 | 4.449 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.794649e-05 | 4.421 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.832429e-05 | 4.417 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.023676e-05 | 4.395 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.572765e-05 | 4.340 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.975368e-05 | 4.303 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.182401e-05 | 4.285 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.426003e-05 | 4.266 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.470512e-05 | 4.262 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.285652e-05 | 4.202 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.996703e-05 | 4.155 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.004022e-05 | 4.155 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.625175e-05 | 4.118 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.766688e-05 | 4.110 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.580151e-05 | 4.067 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.268814e-05 | 4.033 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.022479e-04 | 3.990 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.025654e-04 | 3.989 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.143195e-04 | 3.942 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.288429e-04 | 3.890 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.288429e-04 | 3.890 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.288745e-04 | 3.890 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.404037e-04 | 3.853 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.413852e-04 | 3.850 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.447305e-04 | 3.839 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.447305e-04 | 3.839 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.625917e-04 | 3.789 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.814358e-04 | 3.741 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.042427e-04 | 3.690 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.349430e-04 | 3.629 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.349430e-04 | 3.629 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.799743e-04 | 3.553 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.921008e-04 | 3.534 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.079014e-04 | 3.512 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.989200e-04 | 3.524 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.125652e-04 | 3.505 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.301621e-04 | 3.481 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.593991e-04 | 3.444 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.690845e-04 | 3.433 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.037010e-04 | 3.394 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.334352e-04 | 3.363 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.133010e-04 | 3.384 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.407573e-04 | 3.356 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.414829e-04 | 3.355 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.515270e-04 | 3.345 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.679582e-04 | 3.330 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.338004e-04 | 3.273 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.443787e-04 | 3.264 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.552819e-04 | 3.255 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.528569e-04 | 3.185 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.364552e-04 | 3.196 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.528569e-04 | 3.185 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.093970e-04 | 3.215 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.093970e-04 | 3.215 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.631481e-04 | 3.178 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.704199e-04 | 3.174 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.804597e-04 | 3.167 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.566922e-04 | 3.121 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.757827e-04 | 3.110 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.430129e-04 | 3.074 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.284894e-04 | 3.032 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.598017e-04 | 3.066 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.021330e-04 | 3.045 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.346975e-04 | 3.029 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.021527e-03 | 2.991 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.081316e-03 | 2.966 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.182986e-03 | 2.927 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.213662e-03 | 2.916 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.225129e-03 | 2.912 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.255244e-03 | 2.901 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.319917e-03 | 2.879 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.368881e-03 | 2.864 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.484289e-03 | 2.828 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.467596e-03 | 2.833 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.368976e-03 | 2.864 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.362607e-03 | 2.866 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.569834e-03 | 2.804 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.569834e-03 | 2.804 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.569834e-03 | 2.804 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.569834e-03 | 2.804 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.569834e-03 | 2.804 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.569834e-03 | 2.804 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.569834e-03 | 2.804 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.569834e-03 | 2.804 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.569834e-03 | 2.804 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.569834e-03 | 2.804 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.569834e-03 | 2.804 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.578307e-03 | 2.802 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.540831e-03 | 2.812 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.540831e-03 | 2.812 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.705909e-03 | 2.768 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.664270e-03 | 2.779 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.629524e-03 | 2.788 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.550042e-03 | 2.810 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.763320e-03 | 2.754 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.763320e-03 | 2.754 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.763320e-03 | 2.754 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.822792e-03 | 2.739 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.846453e-03 | 2.734 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.856423e-03 | 2.731 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.856423e-03 | 2.731 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.905271e-03 | 2.720 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.921131e-03 | 2.716 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.004567e-03 | 2.698 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.019845e-03 | 2.695 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.041650e-03 | 2.690 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.063469e-03 | 2.685 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.065957e-03 | 2.685 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.100527e-03 | 2.678 | 0 | 0 |
| Translation | R-HSA-72766 | 2.134651e-03 | 2.671 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.208728e-03 | 2.656 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.292199e-03 | 2.640 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.527104e-03 | 2.597 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.523865e-03 | 2.598 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.527104e-03 | 2.597 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.667246e-03 | 2.574 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.673562e-03 | 2.573 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.683363e-03 | 2.571 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.714685e-03 | 2.566 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.760034e-03 | 2.559 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.848269e-03 | 2.545 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.848269e-03 | 2.545 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.848269e-03 | 2.545 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.915013e-03 | 2.535 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.954530e-03 | 2.530 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.070667e-03 | 2.513 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.115983e-03 | 2.506 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.277068e-03 | 2.485 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.531439e-03 | 2.452 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.432708e-03 | 2.464 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.432708e-03 | 2.464 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.774921e-03 | 2.423 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.569804e-03 | 2.447 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.774921e-03 | 2.423 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.531240e-03 | 2.452 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.689727e-03 | 2.433 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.634856e-03 | 2.440 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.774921e-03 | 2.423 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.733379e-03 | 2.428 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.735125e-03 | 2.428 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.848750e-03 | 2.415 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.850773e-03 | 2.414 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.007427e-03 | 2.397 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.007427e-03 | 2.397 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.012267e-03 | 2.397 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.031030e-03 | 2.395 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.049929e-03 | 2.393 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.255459e-03 | 2.371 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.301559e-03 | 2.366 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.364773e-03 | 2.360 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.656230e-03 | 2.332 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.946455e-03 | 2.306 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.097461e-03 | 2.293 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.189399e-03 | 2.285 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.189399e-03 | 2.285 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.189399e-03 | 2.285 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.189684e-03 | 2.285 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.189684e-03 | 2.285 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.190690e-03 | 2.285 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.227564e-03 | 2.282 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.310342e-03 | 2.275 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.629039e-03 | 2.250 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.629039e-03 | 2.250 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.347558e-03 | 2.272 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.756417e-03 | 2.240 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.372623e-03 | 2.270 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.372623e-03 | 2.270 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.004772e-03 | 2.222 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.167588e-03 | 2.210 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.872167e-03 | 2.231 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.004772e-03 | 2.222 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.622407e-03 | 2.250 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.220398e-03 | 2.206 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.216242e-03 | 2.206 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.897687e-03 | 2.229 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.224271e-03 | 2.206 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.562630e-03 | 2.183 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.562630e-03 | 2.183 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.562630e-03 | 2.183 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 6.574185e-03 | 2.182 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.737593e-03 | 2.171 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.931031e-03 | 2.159 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.032351e-03 | 2.153 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.359996e-03 | 2.133 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.359996e-03 | 2.133 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.788920e-03 | 2.109 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 8.077791e-03 | 2.093 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.120549e-03 | 2.090 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.135768e-03 | 2.090 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.467369e-03 | 2.072 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.467369e-03 | 2.072 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.486094e-03 | 2.071 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.542131e-03 | 2.068 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.664372e-03 | 2.062 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.778594e-03 | 2.057 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.022035e-03 | 2.045 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.069198e-03 | 2.042 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.069198e-03 | 2.042 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.087224e-02 | 1.964 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.087224e-02 | 1.964 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.431197e-03 | 2.025 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.072297e-02 | 1.970 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.095960e-02 | 1.960 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.084340e-02 | 1.965 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.087224e-02 | 1.964 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.072297e-02 | 1.970 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 9.431197e-03 | 2.025 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.087224e-02 | 1.964 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.012788e-02 | 1.994 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.689470e-03 | 2.014 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.099359e-02 | 1.959 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.053692e-02 | 1.977 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.334158e-03 | 2.030 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.370403e-03 | 2.028 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.103564e-02 | 1.957 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.012788e-02 | 1.994 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.431197e-03 | 2.025 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.038318e-02 | 1.984 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.334158e-03 | 2.030 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.152787e-02 | 1.938 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.184250e-02 | 1.927 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.184743e-02 | 1.926 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.189616e-02 | 1.925 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.201730e-02 | 1.920 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.201730e-02 | 1.920 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.208417e-02 | 1.918 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.208417e-02 | 1.918 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.219247e-02 | 1.914 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.219879e-02 | 1.914 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.237987e-02 | 1.907 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.257721e-02 | 1.900 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.257721e-02 | 1.900 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.270074e-02 | 1.896 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.275787e-02 | 1.894 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.275787e-02 | 1.894 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.275787e-02 | 1.894 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.313630e-02 | 1.882 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.313630e-02 | 1.882 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.313630e-02 | 1.882 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.320144e-02 | 1.879 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.344923e-02 | 1.871 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.345742e-02 | 1.871 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.356199e-02 | 1.868 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.413485e-02 | 1.850 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.413485e-02 | 1.850 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.438167e-02 | 1.842 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.449373e-02 | 1.839 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.470752e-02 | 1.832 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.497477e-02 | 1.825 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.497477e-02 | 1.825 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.505695e-02 | 1.822 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.540261e-02 | 1.812 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.540261e-02 | 1.812 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.550837e-02 | 1.809 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.571285e-02 | 1.804 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.582909e-02 | 1.801 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.721787e-02 | 1.764 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.721787e-02 | 1.764 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.721787e-02 | 1.764 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.721787e-02 | 1.764 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.721787e-02 | 1.764 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.895244e-02 | 1.722 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.895244e-02 | 1.722 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.797222e-02 | 1.745 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.710639e-02 | 1.767 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.936170e-02 | 1.713 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.719568e-02 | 1.765 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.750971e-02 | 1.757 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.721787e-02 | 1.764 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.654438e-02 | 1.781 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.044281e-02 | 1.689 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.887870e-02 | 1.724 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.721787e-02 | 1.764 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.886224e-02 | 1.724 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.967769e-02 | 1.706 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.895244e-02 | 1.722 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.795044e-02 | 1.746 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.721787e-02 | 1.764 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.721787e-02 | 1.764 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.721787e-02 | 1.764 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.075845e-02 | 1.683 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.079892e-02 | 1.682 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.095111e-02 | 1.679 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.109238e-02 | 1.676 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.137073e-02 | 1.670 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.168148e-02 | 1.664 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.168148e-02 | 1.664 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.178427e-02 | 1.662 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.187979e-02 | 1.660 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.240899e-02 | 1.650 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.240899e-02 | 1.650 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.259934e-02 | 1.646 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.288289e-02 | 1.640 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.288289e-02 | 1.640 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.288289e-02 | 1.640 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.297925e-02 | 1.639 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.314799e-02 | 1.635 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.395021e-02 | 1.621 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.395021e-02 | 1.621 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.409153e-02 | 1.618 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.409153e-02 | 1.618 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.409153e-02 | 1.618 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.409153e-02 | 1.618 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.409153e-02 | 1.618 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.409153e-02 | 1.618 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.448309e-02 | 1.611 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.486207e-02 | 1.604 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.486207e-02 | 1.604 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.486207e-02 | 1.604 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.508206e-02 | 1.601 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.508206e-02 | 1.601 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.508206e-02 | 1.601 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.508206e-02 | 1.601 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.508206e-02 | 1.601 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.508206e-02 | 1.601 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.508206e-02 | 1.601 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.512321e-02 | 1.600 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.512321e-02 | 1.600 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.512321e-02 | 1.600 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.520774e-02 | 1.598 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.520774e-02 | 1.598 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.520774e-02 | 1.598 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.565277e-02 | 1.591 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.565277e-02 | 1.591 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.748062e-02 | 1.561 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.828164e-02 | 1.548 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.917135e-02 | 1.535 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.917135e-02 | 1.535 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.947595e-02 | 1.531 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.950902e-02 | 1.530 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.950902e-02 | 1.530 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.018815e-02 | 1.520 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.018815e-02 | 1.520 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.018815e-02 | 1.520 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.018815e-02 | 1.520 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.018815e-02 | 1.520 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.110635e-02 | 1.507 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.117931e-02 | 1.506 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.133166e-02 | 1.504 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.133166e-02 | 1.504 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.143014e-02 | 1.503 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.239672e-02 | 1.489 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.239672e-02 | 1.489 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.761418e-02 | 1.425 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.761418e-02 | 1.425 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.761418e-02 | 1.425 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.489733e-02 | 1.457 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.489733e-02 | 1.457 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.489733e-02 | 1.457 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.721498e-02 | 1.429 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.968903e-02 | 1.401 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.888494e-02 | 1.410 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.888494e-02 | 1.410 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.727724e-02 | 1.429 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.556224e-02 | 1.449 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.556224e-02 | 1.449 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.544535e-02 | 1.450 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.544535e-02 | 1.450 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.169068e-02 | 1.380 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.761418e-02 | 1.425 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.959763e-02 | 1.402 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.320487e-02 | 1.364 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.544535e-02 | 1.450 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.046913e-02 | 1.393 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.780684e-02 | 1.422 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.721498e-02 | 1.429 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.454510e-02 | 1.462 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.644001e-02 | 1.438 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.959763e-02 | 1.402 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.179957e-02 | 1.379 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.430257e-02 | 1.354 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.434247e-02 | 1.353 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.509560e-02 | 1.346 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.519491e-02 | 1.345 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.520812e-02 | 1.345 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.542569e-02 | 1.343 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.542569e-02 | 1.343 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 4.562329e-02 | 1.341 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.562329e-02 | 1.341 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.563783e-02 | 1.341 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.601504e-02 | 1.337 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.610205e-02 | 1.336 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.618509e-02 | 1.335 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.658598e-02 | 1.332 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.658598e-02 | 1.332 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.658598e-02 | 1.332 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.658598e-02 | 1.332 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 4.658598e-02 | 1.332 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.659698e-02 | 1.332 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.659698e-02 | 1.332 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.744250e-02 | 1.324 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.744250e-02 | 1.324 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.744250e-02 | 1.324 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.744250e-02 | 1.324 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.744250e-02 | 1.324 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.744250e-02 | 1.324 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.744250e-02 | 1.324 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.744250e-02 | 1.324 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.784979e-02 | 1.320 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.915832e-02 | 1.308 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.926362e-02 | 1.307 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.936033e-02 | 1.307 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.936033e-02 | 1.307 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.062319e-02 | 1.296 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.079107e-02 | 1.294 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.120937e-02 | 1.291 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.120937e-02 | 1.291 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.120937e-02 | 1.291 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.120937e-02 | 1.291 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.179904e-02 | 1.286 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 5.216140e-02 | 1.283 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.216140e-02 | 1.283 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.216140e-02 | 1.283 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.257386e-02 | 1.279 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.282879e-02 | 1.277 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.474860e-02 | 1.262 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.474860e-02 | 1.262 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.474860e-02 | 1.262 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.474860e-02 | 1.262 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.528513e-02 | 1.257 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.570494e-02 | 1.254 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.570494e-02 | 1.254 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.626501e-02 | 1.250 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.647438e-02 | 1.248 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.647438e-02 | 1.248 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.018814e-02 | 1.220 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.018814e-02 | 1.220 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.840316e-02 | 1.234 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.428144e-02 | 1.074 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.418354e-02 | 1.193 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.752168e-02 | 1.240 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.752168e-02 | 1.240 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.518349e-02 | 1.124 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.518349e-02 | 1.124 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.700834e-02 | 1.174 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.700834e-02 | 1.174 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.623231e-02 | 1.179 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.550592e-02 | 1.068 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.550592e-02 | 1.068 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.472014e-02 | 1.189 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.472014e-02 | 1.189 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.948042e-02 | 1.158 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.948042e-02 | 1.158 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.669301e-02 | 1.176 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.669301e-02 | 1.176 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.664832e-02 | 1.115 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.325456e-02 | 1.135 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.807826e-02 | 1.236 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.433950e-02 | 1.129 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.510134e-02 | 1.070 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.623231e-02 | 1.179 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.518349e-02 | 1.124 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.296748e-02 | 1.081 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.296748e-02 | 1.081 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.601696e-02 | 1.180 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.207512e-02 | 1.142 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.287561e-02 | 1.202 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.700834e-02 | 1.174 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.428144e-02 | 1.074 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.472014e-02 | 1.189 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.018814e-02 | 1.220 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.428144e-02 | 1.074 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.522554e-02 | 1.186 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.426884e-02 | 1.129 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.426884e-02 | 1.129 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.408179e-02 | 1.075 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.646189e-02 | 1.117 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.623258e-02 | 1.118 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.623258e-02 | 1.118 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.623258e-02 | 1.118 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.623258e-02 | 1.118 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.510134e-02 | 1.070 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.786518e-02 | 1.238 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.503343e-02 | 1.187 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.442810e-02 | 1.128 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.428144e-02 | 1.074 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.591823e-02 | 1.120 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.068902e-02 | 1.151 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.623258e-02 | 1.118 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.433950e-02 | 1.129 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.752168e-02 | 1.240 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.840316e-02 | 1.234 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.068902e-02 | 1.151 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.472014e-02 | 1.189 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.815003e-02 | 1.235 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.385771e-02 | 1.076 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.275764e-02 | 1.202 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.018814e-02 | 1.220 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.418354e-02 | 1.193 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.993510e-02 | 1.097 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.428144e-02 | 1.074 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.566132e-02 | 1.121 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 8.578268e-02 | 1.067 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 8.578268e-02 | 1.067 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.669377e-02 | 1.062 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.718545e-02 | 1.060 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.718545e-02 | 1.060 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.830265e-02 | 1.054 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.830265e-02 | 1.054 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.830265e-02 | 1.054 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.942837e-02 | 1.049 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.009891e-02 | 1.045 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.220598e-02 | 1.035 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 9.292749e-02 | 1.032 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.535319e-02 | 1.021 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.535319e-02 | 1.021 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.576885e-02 | 1.019 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.717780e-02 | 1.012 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.717780e-02 | 1.012 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 9.794606e-02 | 1.009 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 9.794606e-02 | 1.009 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 9.794606e-02 | 1.009 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.914448e-02 | 1.004 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.914448e-02 | 1.004 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.918455e-02 | 1.004 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.918455e-02 | 1.004 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.001469e-01 | 0.999 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.001720e-01 | 0.999 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.001720e-01 | 0.999 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.020226e-01 | 0.991 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 1.053622e-01 | 0.977 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.067000e-01 | 0.972 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.067000e-01 | 0.972 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.067000e-01 | 0.972 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.109136e-01 | 0.955 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.109136e-01 | 0.955 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.109136e-01 | 0.955 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.109136e-01 | 0.955 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.118793e-01 | 0.951 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.118793e-01 | 0.951 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.118793e-01 | 0.951 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.121076e-01 | 0.950 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.124114e-01 | 0.949 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.124114e-01 | 0.949 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.124114e-01 | 0.949 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.124114e-01 | 0.949 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.141160e-01 | 0.943 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.141160e-01 | 0.943 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.141160e-01 | 0.943 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.141757e-01 | 0.942 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.142740e-01 | 0.942 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.142740e-01 | 0.942 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.152266e-01 | 0.938 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.152266e-01 | 0.938 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.152266e-01 | 0.938 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.152266e-01 | 0.938 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.152266e-01 | 0.938 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.152266e-01 | 0.938 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.164387e-01 | 0.934 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.164387e-01 | 0.934 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.164387e-01 | 0.934 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.164387e-01 | 0.934 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.182878e-01 | 0.927 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.182878e-01 | 0.927 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.182878e-01 | 0.927 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.192278e-01 | 0.924 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.192278e-01 | 0.924 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.210864e-01 | 0.917 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.215282e-01 | 0.915 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.216642e-01 | 0.915 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.216642e-01 | 0.915 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.216642e-01 | 0.915 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.216642e-01 | 0.915 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.233632e-01 | 0.909 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.233632e-01 | 0.909 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.233632e-01 | 0.909 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.233632e-01 | 0.909 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.233632e-01 | 0.909 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.233632e-01 | 0.909 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.233867e-01 | 0.909 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.233867e-01 | 0.909 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.233867e-01 | 0.909 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.233867e-01 | 0.909 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.240987e-01 | 0.906 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.240987e-01 | 0.906 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.240987e-01 | 0.906 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.240987e-01 | 0.906 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.249835e-01 | 0.903 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.251812e-01 | 0.902 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.258699e-01 | 0.900 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 2.154953e-01 | 0.667 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 2.154953e-01 | 0.667 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 2.154953e-01 | 0.667 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.154953e-01 | 0.667 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.154953e-01 | 0.667 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.154953e-01 | 0.667 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.655985e-01 | 0.781 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.655985e-01 | 0.781 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.655985e-01 | 0.781 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.655985e-01 | 0.781 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.655985e-01 | 0.781 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.090550e-01 | 0.680 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.090550e-01 | 0.680 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.509178e-01 | 0.821 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.509178e-01 | 0.821 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.509178e-01 | 0.821 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.509178e-01 | 0.821 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.509178e-01 | 0.821 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.323859e-01 | 0.878 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.323859e-01 | 0.878 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.323859e-01 | 0.878 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.323859e-01 | 0.878 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.323859e-01 | 0.878 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.323859e-01 | 0.878 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.323859e-01 | 0.878 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.801731e-01 | 0.744 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.801731e-01 | 0.744 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.801731e-01 | 0.744 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.801731e-01 | 0.744 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.801731e-01 | 0.744 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.542992e-01 | 0.812 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.542992e-01 | 0.812 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.542992e-01 | 0.812 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.542992e-01 | 0.812 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.107920e-01 | 0.676 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.107920e-01 | 0.676 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.107920e-01 | 0.676 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.324629e-01 | 0.878 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.324629e-01 | 0.878 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.324629e-01 | 0.878 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.324629e-01 | 0.878 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.289820e-01 | 0.889 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.424291e-01 | 0.615 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.424291e-01 | 0.615 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.424291e-01 | 0.615 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.424291e-01 | 0.615 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.424291e-01 | 0.615 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.016953e-01 | 0.695 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.016953e-01 | 0.695 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.612979e-01 | 0.792 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.902856e-01 | 0.721 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.268383e-01 | 0.644 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 2.268383e-01 | 0.644 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.268383e-01 | 0.644 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.305167e-01 | 0.884 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.522414e-01 | 0.817 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.527160e-01 | 0.597 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.527160e-01 | 0.597 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.527160e-01 | 0.597 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.268123e-01 | 0.897 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.153895e-01 | 0.667 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.987115e-01 | 0.702 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.356215e-01 | 0.628 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.450868e-01 | 0.611 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.927909e-01 | 0.715 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.927909e-01 | 0.715 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.607828e-01 | 0.794 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.507767e-01 | 0.822 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.348658e-01 | 0.870 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.996164e-01 | 0.700 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.433672e-01 | 0.844 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.927909e-01 | 0.715 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.966932e-01 | 0.706 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.714379e-01 | 0.766 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.542992e-01 | 0.812 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.786408e-01 | 0.748 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.305167e-01 | 0.884 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.402233e-01 | 0.853 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.107920e-01 | 0.676 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.324629e-01 | 0.878 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.996164e-01 | 0.700 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.348658e-01 | 0.870 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.107920e-01 | 0.676 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.829882e-01 | 0.738 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.433672e-01 | 0.844 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.323859e-01 | 0.878 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.153895e-01 | 0.667 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.655985e-01 | 0.781 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 1.522414e-01 | 0.817 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 1.786408e-01 | 0.748 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.471824e-01 | 0.832 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.500763e-01 | 0.602 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.500763e-01 | 0.602 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.112885e-01 | 0.675 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.966932e-01 | 0.706 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.064381e-01 | 0.685 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.376692e-01 | 0.861 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.301471e-01 | 0.638 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.334847e-01 | 0.875 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.368906e-01 | 0.625 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.469042e-01 | 0.833 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.090550e-01 | 0.680 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.433672e-01 | 0.844 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.433672e-01 | 0.844 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.527160e-01 | 0.597 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.348658e-01 | 0.870 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.348658e-01 | 0.870 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.000185e-01 | 0.699 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.483797e-01 | 0.605 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.064381e-01 | 0.685 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.441491e-01 | 0.841 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.090550e-01 | 0.680 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.501173e-01 | 0.824 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.016953e-01 | 0.695 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.376692e-01 | 0.861 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.688036e-01 | 0.773 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.144177e-01 | 0.669 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.674130e-01 | 0.776 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.521906e-01 | 0.818 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.093874e-01 | 0.679 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.409928e-01 | 0.618 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.107920e-01 | 0.676 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.107920e-01 | 0.676 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.708363e-01 | 0.767 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.725137e-01 | 0.763 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.000185e-01 | 0.699 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.996164e-01 | 0.700 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.339941e-01 | 0.631 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.892724e-01 | 0.723 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.099192e-01 | 0.678 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.556379e-01 | 0.808 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.684773e-01 | 0.773 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.580151e-01 | 0.801 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.154953e-01 | 0.667 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.655985e-01 | 0.781 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.655985e-01 | 0.781 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.090550e-01 | 0.680 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 1.801731e-01 | 0.744 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.424291e-01 | 0.615 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.568160e-01 | 0.805 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.708363e-01 | 0.767 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.725137e-01 | 0.763 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.346611e-01 | 0.630 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.000185e-01 | 0.699 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.483797e-01 | 0.605 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.054587e-01 | 0.687 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.996164e-01 | 0.700 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.424448e-01 | 0.846 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.451950e-01 | 0.610 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.323859e-01 | 0.878 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.284450e-01 | 0.891 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.348658e-01 | 0.870 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.917807e-01 | 0.717 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.192499e-01 | 0.659 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.542992e-01 | 0.812 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.519165e-01 | 0.818 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.674130e-01 | 0.776 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.801731e-01 | 0.744 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.107920e-01 | 0.676 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.289820e-01 | 0.889 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.424291e-01 | 0.615 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.966932e-01 | 0.706 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.999562e-01 | 0.699 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.090550e-01 | 0.680 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.305167e-01 | 0.884 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.433672e-01 | 0.844 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.483797e-01 | 0.605 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.483797e-01 | 0.605 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.083107e-01 | 0.681 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.892724e-01 | 0.723 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.346611e-01 | 0.630 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.483735e-01 | 0.605 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.343666e-01 | 0.630 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 1.700821e-01 | 0.769 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.323859e-01 | 0.878 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.323859e-01 | 0.878 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.329881e-01 | 0.633 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.568160e-01 | 0.805 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.461993e-01 | 0.609 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.329881e-01 | 0.633 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 2.107920e-01 | 0.676 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.507767e-01 | 0.822 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.704149e-01 | 0.768 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.323859e-01 | 0.878 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.801731e-01 | 0.744 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.503674e-01 | 0.823 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.700821e-01 | 0.769 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.380610e-01 | 0.623 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.090550e-01 | 0.680 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.305167e-01 | 0.884 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.527160e-01 | 0.597 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.832192e-01 | 0.737 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.902856e-01 | 0.721 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.268383e-01 | 0.644 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.483797e-01 | 0.605 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.507767e-01 | 0.822 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.339941e-01 | 0.631 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.534798e-01 | 0.596 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.534798e-01 | 0.596 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.534798e-01 | 0.596 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.534798e-01 | 0.596 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.534798e-01 | 0.596 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.544372e-01 | 0.594 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.545046e-01 | 0.594 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.545046e-01 | 0.594 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 2.545046e-01 | 0.594 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.552802e-01 | 0.593 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.565392e-01 | 0.591 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.571795e-01 | 0.590 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.598541e-01 | 0.585 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.629675e-01 | 0.580 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.629675e-01 | 0.580 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 2.651196e-01 | 0.577 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.670926e-01 | 0.573 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.701454e-01 | 0.568 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.701454e-01 | 0.568 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.746459e-01 | 0.561 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.746459e-01 | 0.561 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.747601e-01 | 0.561 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.747601e-01 | 0.561 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.747601e-01 | 0.561 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 2.747601e-01 | 0.561 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.747601e-01 | 0.561 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.747601e-01 | 0.561 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 2.747601e-01 | 0.561 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.747601e-01 | 0.561 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.747601e-01 | 0.561 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.780597e-01 | 0.556 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.780597e-01 | 0.556 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.780597e-01 | 0.556 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.780597e-01 | 0.556 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.791599e-01 | 0.554 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.791599e-01 | 0.554 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.791599e-01 | 0.554 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.791599e-01 | 0.554 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.836038e-01 | 0.547 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.842018e-01 | 0.546 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.887542e-01 | 0.539 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.887542e-01 | 0.539 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.892294e-01 | 0.539 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.916941e-01 | 0.535 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.916941e-01 | 0.535 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.952146e-01 | 0.530 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.952146e-01 | 0.530 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.952146e-01 | 0.530 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.980845e-01 | 0.526 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.980845e-01 | 0.526 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.980845e-01 | 0.526 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.994070e-01 | 0.524 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.994070e-01 | 0.524 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 2.994070e-01 | 0.524 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.012229e-01 | 0.521 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.012229e-01 | 0.521 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.041550e-01 | 0.517 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.051543e-01 | 0.515 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.051543e-01 | 0.515 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.051543e-01 | 0.515 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.051543e-01 | 0.515 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.051543e-01 | 0.515 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.051543e-01 | 0.515 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.051543e-01 | 0.515 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.051543e-01 | 0.515 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.051543e-01 | 0.515 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 3.051543e-01 | 0.515 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.051543e-01 | 0.515 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.051543e-01 | 0.515 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.051543e-01 | 0.515 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.051543e-01 | 0.515 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 3.051543e-01 | 0.515 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.051543e-01 | 0.515 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.051543e-01 | 0.515 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.051543e-01 | 0.515 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.051543e-01 | 0.515 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.051543e-01 | 0.515 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.060073e-01 | 0.514 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 3.060073e-01 | 0.514 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.060073e-01 | 0.514 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.060073e-01 | 0.514 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.060073e-01 | 0.514 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.060073e-01 | 0.514 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 3.060073e-01 | 0.514 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.060073e-01 | 0.514 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.071451e-01 | 0.513 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.074865e-01 | 0.512 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.074865e-01 | 0.512 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 3.074865e-01 | 0.512 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 3.074865e-01 | 0.512 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.076468e-01 | 0.512 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.076468e-01 | 0.512 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.079795e-01 | 0.511 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.079795e-01 | 0.511 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.081830e-01 | 0.511 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.107625e-01 | 0.508 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 3.148128e-01 | 0.502 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.151352e-01 | 0.502 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 3.156411e-01 | 0.501 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.194455e-01 | 0.496 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.195194e-01 | 0.496 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.204296e-01 | 0.494 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.246680e-01 | 0.489 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.246680e-01 | 0.489 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.303909e-01 | 0.481 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.305620e-01 | 0.481 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.331028e-01 | 0.477 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.331028e-01 | 0.477 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.331028e-01 | 0.477 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.331028e-01 | 0.477 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.331028e-01 | 0.477 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.342777e-01 | 0.476 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.348339e-01 | 0.475 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.348339e-01 | 0.475 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.348339e-01 | 0.475 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.371443e-01 | 0.472 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.371443e-01 | 0.472 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.371443e-01 | 0.472 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.371443e-01 | 0.472 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.371443e-01 | 0.472 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.371443e-01 | 0.472 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.371443e-01 | 0.472 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.403374e-01 | 0.468 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.403374e-01 | 0.468 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.403374e-01 | 0.468 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 3.403374e-01 | 0.468 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.403374e-01 | 0.468 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.403374e-01 | 0.468 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.422482e-01 | 0.466 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.422482e-01 | 0.466 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.422482e-01 | 0.466 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.422482e-01 | 0.466 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.450160e-01 | 0.462 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.460681e-01 | 0.461 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.461128e-01 | 0.461 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.462953e-01 | 0.461 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.482962e-01 | 0.458 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.482962e-01 | 0.458 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.482962e-01 | 0.458 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.482962e-01 | 0.458 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.533274e-01 | 0.452 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.533274e-01 | 0.452 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.533274e-01 | 0.452 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.583645e-01 | 0.446 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.603004e-01 | 0.443 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 3.603004e-01 | 0.443 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.603004e-01 | 0.443 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.603004e-01 | 0.443 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.603004e-01 | 0.443 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.603004e-01 | 0.443 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.652091e-01 | 0.437 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.654910e-01 | 0.437 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.654910e-01 | 0.437 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.654910e-01 | 0.437 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.680689e-01 | 0.434 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.720131e-01 | 0.429 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.730714e-01 | 0.428 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 3.730714e-01 | 0.428 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 3.730714e-01 | 0.428 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 3.730714e-01 | 0.428 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.732992e-01 | 0.428 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.732992e-01 | 0.428 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.747630e-01 | 0.426 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 3.796642e-01 | 0.421 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.796642e-01 | 0.421 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.803283e-01 | 0.420 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.845710e-01 | 0.415 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.845710e-01 | 0.415 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.845710e-01 | 0.415 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 3.845710e-01 | 0.415 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.845710e-01 | 0.415 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.845710e-01 | 0.415 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.845710e-01 | 0.415 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.845710e-01 | 0.415 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.849866e-01 | 0.415 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.850952e-01 | 0.414 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.854894e-01 | 0.414 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.854894e-01 | 0.414 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.854894e-01 | 0.414 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.854894e-01 | 0.414 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.854894e-01 | 0.414 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.854894e-01 | 0.414 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.860984e-01 | 0.413 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.868975e-01 | 0.412 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.874640e-01 | 0.412 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.874640e-01 | 0.412 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.874640e-01 | 0.412 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.874640e-01 | 0.412 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 3.874640e-01 | 0.412 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.880158e-01 | 0.411 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.880158e-01 | 0.411 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.888391e-01 | 0.410 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.917004e-01 | 0.407 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.957288e-01 | 0.403 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.957288e-01 | 0.403 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.957288e-01 | 0.403 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.957288e-01 | 0.403 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.987067e-01 | 0.399 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.009785e-01 | 0.397 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.045052e-01 | 0.393 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.045052e-01 | 0.393 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.045052e-01 | 0.393 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 4.054757e-01 | 0.392 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.054757e-01 | 0.392 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.054757e-01 | 0.392 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 4.054757e-01 | 0.392 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.054757e-01 | 0.392 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.054757e-01 | 0.392 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.054757e-01 | 0.392 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.054757e-01 | 0.392 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.107133e-01 | 0.386 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.107537e-01 | 0.386 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.193587e-01 | 0.377 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.193587e-01 | 0.377 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.193587e-01 | 0.377 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.251672e-01 | 0.371 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.251672e-01 | 0.371 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.274422e-01 | 0.369 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.274422e-01 | 0.369 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.274422e-01 | 0.369 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.274422e-01 | 0.369 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.274422e-01 | 0.369 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.274422e-01 | 0.369 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.274422e-01 | 0.369 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.274422e-01 | 0.369 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.274422e-01 | 0.369 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.274422e-01 | 0.369 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.373663e-01 | 0.359 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.373663e-01 | 0.359 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.373663e-01 | 0.359 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.411999e-01 | 0.355 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.431017e-01 | 0.353 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.434218e-01 | 0.353 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.434218e-01 | 0.353 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.536809e-01 | 0.343 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.549150e-01 | 0.342 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.549150e-01 | 0.342 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.549150e-01 | 0.342 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.549150e-01 | 0.342 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.549150e-01 | 0.342 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.549150e-01 | 0.342 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.549150e-01 | 0.342 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.594440e-01 | 0.338 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.594440e-01 | 0.338 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.627303e-01 | 0.335 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.627303e-01 | 0.335 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.627303e-01 | 0.335 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.660516e-01 | 0.332 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.662417e-01 | 0.331 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.675562e-01 | 0.330 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.675562e-01 | 0.330 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.675562e-01 | 0.330 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.675562e-01 | 0.330 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.678365e-01 | 0.330 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.678365e-01 | 0.330 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.678365e-01 | 0.330 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.678365e-01 | 0.330 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.678365e-01 | 0.330 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.678365e-01 | 0.330 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.685862e-01 | 0.329 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.685862e-01 | 0.329 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.692611e-01 | 0.329 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.699953e-01 | 0.328 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.762273e-01 | 0.322 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.818832e-01 | 0.317 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.818832e-01 | 0.317 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.851917e-01 | 0.314 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.851917e-01 | 0.314 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.889749e-01 | 0.311 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.890529e-01 | 0.311 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.934464e-01 | 0.307 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.990038e-01 | 0.302 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.990038e-01 | 0.302 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.990038e-01 | 0.302 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.057177e-01 | 0.296 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.057177e-01 | 0.296 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.057177e-01 | 0.296 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.064805e-01 | 0.295 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.064805e-01 | 0.295 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.064805e-01 | 0.295 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.064805e-01 | 0.295 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.064805e-01 | 0.295 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.115334e-01 | 0.291 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.133237e-01 | 0.290 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.141468e-01 | 0.289 | 0 | 0 |
| Alternative complement activation | R-HSA-173736 | 5.172222e-01 | 0.286 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.172222e-01 | 0.286 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.172222e-01 | 0.286 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.172222e-01 | 0.286 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.172222e-01 | 0.286 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 5.172222e-01 | 0.286 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.187911e-01 | 0.285 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.187911e-01 | 0.285 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.187911e-01 | 0.285 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.195700e-01 | 0.284 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.195700e-01 | 0.284 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.285114e-01 | 0.277 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.285114e-01 | 0.277 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.285114e-01 | 0.277 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.285114e-01 | 0.277 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.321398e-01 | 0.274 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.336730e-01 | 0.273 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.336730e-01 | 0.273 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.356235e-01 | 0.271 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.356235e-01 | 0.271 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.356235e-01 | 0.271 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.432466e-01 | 0.265 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.432466e-01 | 0.265 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.432466e-01 | 0.265 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.435216e-01 | 0.265 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.435216e-01 | 0.265 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.458172e-01 | 0.263 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.458172e-01 | 0.263 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.458172e-01 | 0.263 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.498743e-01 | 0.260 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.513319e-01 | 0.259 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.553456e-01 | 0.255 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.553456e-01 | 0.255 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.553456e-01 | 0.255 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 5.570231e-01 | 0.254 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 5.570231e-01 | 0.254 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.570231e-01 | 0.254 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.620134e-01 | 0.250 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.642764e-01 | 0.249 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.675797e-01 | 0.246 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.675797e-01 | 0.246 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 5.675797e-01 | 0.246 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.706140e-01 | 0.244 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.724105e-01 | 0.242 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.724105e-01 | 0.242 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.724105e-01 | 0.242 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.724105e-01 | 0.242 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.724105e-01 | 0.242 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.724105e-01 | 0.242 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.724105e-01 | 0.242 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.724105e-01 | 0.242 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 5.724105e-01 | 0.242 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.724105e-01 | 0.242 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.724105e-01 | 0.242 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.724105e-01 | 0.242 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.724105e-01 | 0.242 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.724105e-01 | 0.242 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.724105e-01 | 0.242 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 5.724105e-01 | 0.242 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.724105e-01 | 0.242 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.724105e-01 | 0.242 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.736042e-01 | 0.241 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.740894e-01 | 0.241 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.765091e-01 | 0.239 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.780592e-01 | 0.238 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.780592e-01 | 0.238 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.780592e-01 | 0.238 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.780592e-01 | 0.238 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.780592e-01 | 0.238 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.780592e-01 | 0.238 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.780592e-01 | 0.238 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.780592e-01 | 0.238 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.780592e-01 | 0.238 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.811361e-01 | 0.236 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.844016e-01 | 0.233 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.844725e-01 | 0.233 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.844725e-01 | 0.233 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.844725e-01 | 0.233 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 5.844725e-01 | 0.233 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.909172e-01 | 0.228 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.957051e-01 | 0.225 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.971275e-01 | 0.224 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.971275e-01 | 0.224 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.981391e-01 | 0.223 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.030483e-01 | 0.220 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.100325e-01 | 0.215 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.108109e-01 | 0.214 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.108109e-01 | 0.214 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.108109e-01 | 0.214 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.108109e-01 | 0.214 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.108109e-01 | 0.214 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.108845e-01 | 0.214 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.108845e-01 | 0.214 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.132330e-01 | 0.212 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.134949e-01 | 0.212 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.134949e-01 | 0.212 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 6.134949e-01 | 0.212 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.140567e-01 | 0.212 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.140567e-01 | 0.212 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.154776e-01 | 0.211 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.188613e-01 | 0.208 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.206517e-01 | 0.207 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.212310e-01 | 0.207 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.212928e-01 | 0.207 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.212928e-01 | 0.207 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.212928e-01 | 0.207 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.212928e-01 | 0.207 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.212928e-01 | 0.207 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.212928e-01 | 0.207 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.212928e-01 | 0.207 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.212928e-01 | 0.207 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.212928e-01 | 0.207 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.212928e-01 | 0.207 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.212928e-01 | 0.207 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.212928e-01 | 0.207 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.212928e-01 | 0.207 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.212928e-01 | 0.207 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.212928e-01 | 0.207 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.212928e-01 | 0.207 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.216547e-01 | 0.206 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.254259e-01 | 0.204 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.296378e-01 | 0.201 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.352824e-01 | 0.197 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.352824e-01 | 0.197 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.352824e-01 | 0.197 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.352824e-01 | 0.197 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.360055e-01 | 0.197 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.360055e-01 | 0.197 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.366118e-01 | 0.196 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.366118e-01 | 0.196 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.389290e-01 | 0.195 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.389290e-01 | 0.195 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.417219e-01 | 0.193 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.417219e-01 | 0.193 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 6.417219e-01 | 0.193 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 6.417219e-01 | 0.193 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 6.417219e-01 | 0.193 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.417219e-01 | 0.193 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.417219e-01 | 0.193 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.417219e-01 | 0.193 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.417606e-01 | 0.193 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.497004e-01 | 0.187 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.522510e-01 | 0.186 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.554323e-01 | 0.183 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.554323e-01 | 0.183 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.554323e-01 | 0.183 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.600371e-01 | 0.180 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.600371e-01 | 0.180 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.600371e-01 | 0.180 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.600371e-01 | 0.180 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.600371e-01 | 0.180 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.645894e-01 | 0.177 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.645894e-01 | 0.177 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.645894e-01 | 0.177 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.645894e-01 | 0.177 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.645894e-01 | 0.177 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 6.645894e-01 | 0.177 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.645894e-01 | 0.177 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.645894e-01 | 0.177 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 6.645894e-01 | 0.177 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.645894e-01 | 0.177 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.645894e-01 | 0.177 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.645894e-01 | 0.177 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.645894e-01 | 0.177 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.645894e-01 | 0.177 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.705969e-01 | 0.174 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.705969e-01 | 0.174 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.705969e-01 | 0.174 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.705969e-01 | 0.174 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.705969e-01 | 0.174 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.705969e-01 | 0.174 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.705969e-01 | 0.174 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.706983e-01 | 0.173 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.709332e-01 | 0.173 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.728048e-01 | 0.172 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.728048e-01 | 0.172 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.728048e-01 | 0.172 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.729613e-01 | 0.172 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.730227e-01 | 0.172 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.736162e-01 | 0.172 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.736162e-01 | 0.172 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.757893e-01 | 0.170 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.764039e-01 | 0.170 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.797094e-01 | 0.168 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.819330e-01 | 0.166 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.861573e-01 | 0.164 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.861573e-01 | 0.164 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.890833e-01 | 0.162 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.975550e-01 | 0.156 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.975550e-01 | 0.156 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.975550e-01 | 0.156 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.975550e-01 | 0.156 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.975550e-01 | 0.156 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.020746e-01 | 0.154 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.027735e-01 | 0.153 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.029383e-01 | 0.153 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 7.029383e-01 | 0.153 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.029383e-01 | 0.153 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.029383e-01 | 0.153 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.029383e-01 | 0.153 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.029383e-01 | 0.153 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.029383e-01 | 0.153 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.029383e-01 | 0.153 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.029383e-01 | 0.153 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.029383e-01 | 0.153 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.029383e-01 | 0.153 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.029383e-01 | 0.153 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.029383e-01 | 0.153 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.029383e-01 | 0.153 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.045934e-01 | 0.152 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.045934e-01 | 0.152 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.045934e-01 | 0.152 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.080338e-01 | 0.150 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.141846e-01 | 0.146 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.141846e-01 | 0.146 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.141846e-01 | 0.146 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.146443e-01 | 0.146 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.146443e-01 | 0.146 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.147043e-01 | 0.146 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.168397e-01 | 0.145 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.169005e-01 | 0.145 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.222699e-01 | 0.141 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.226570e-01 | 0.141 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 7.226570e-01 | 0.141 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.226570e-01 | 0.141 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.226570e-01 | 0.141 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.226570e-01 | 0.141 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.242573e-01 | 0.140 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.251334e-01 | 0.140 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.251334e-01 | 0.140 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.251334e-01 | 0.140 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.251334e-01 | 0.140 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.251334e-01 | 0.140 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.317675e-01 | 0.136 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.318179e-01 | 0.136 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.369046e-01 | 0.133 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.369046e-01 | 0.133 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.369046e-01 | 0.133 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.369046e-01 | 0.133 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.369046e-01 | 0.133 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.369046e-01 | 0.133 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.369046e-01 | 0.133 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.369046e-01 | 0.133 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.369046e-01 | 0.133 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 7.369046e-01 | 0.133 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.369046e-01 | 0.133 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.372021e-01 | 0.132 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.445382e-01 | 0.128 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.445382e-01 | 0.128 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.445382e-01 | 0.128 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.445382e-01 | 0.128 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.445382e-01 | 0.128 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.445382e-01 | 0.128 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.459749e-01 | 0.127 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.459749e-01 | 0.127 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 7.459749e-01 | 0.127 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.459749e-01 | 0.127 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.628335e-01 | 0.118 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.628335e-01 | 0.118 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.669889e-01 | 0.115 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.669889e-01 | 0.115 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.669889e-01 | 0.115 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.669889e-01 | 0.115 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.669889e-01 | 0.115 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.669889e-01 | 0.115 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.669889e-01 | 0.115 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.669889e-01 | 0.115 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.669889e-01 | 0.115 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.675884e-01 | 0.115 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.675884e-01 | 0.115 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.689954e-01 | 0.114 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.689954e-01 | 0.114 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.725049e-01 | 0.112 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.767421e-01 | 0.110 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.800498e-01 | 0.108 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.800498e-01 | 0.108 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.822867e-01 | 0.107 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.875824e-01 | 0.104 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.875824e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.875824e-01 | 0.104 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.875824e-01 | 0.104 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.875824e-01 | 0.104 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.898499e-01 | 0.102 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.936346e-01 | 0.100 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.936346e-01 | 0.100 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.936346e-01 | 0.100 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.936346e-01 | 0.100 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.936346e-01 | 0.100 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.941782e-01 | 0.100 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.962219e-01 | 0.099 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.060445e-01 | 0.094 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.060445e-01 | 0.094 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.060445e-01 | 0.094 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.078042e-01 | 0.093 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.101229e-01 | 0.091 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.113875e-01 | 0.091 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.113875e-01 | 0.091 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.113875e-01 | 0.091 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.172348e-01 | 0.088 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 8.172348e-01 | 0.088 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.172348e-01 | 0.088 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.172348e-01 | 0.088 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 8.172348e-01 | 0.088 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.172348e-01 | 0.088 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.172348e-01 | 0.088 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.172348e-01 | 0.088 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.172348e-01 | 0.088 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.172348e-01 | 0.088 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.172348e-01 | 0.088 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.172348e-01 | 0.088 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.206853e-01 | 0.086 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.230635e-01 | 0.085 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.255864e-01 | 0.083 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.255864e-01 | 0.083 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.263640e-01 | 0.083 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.294522e-01 | 0.081 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.381372e-01 | 0.077 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.381372e-01 | 0.077 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.381372e-01 | 0.077 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.381372e-01 | 0.077 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.381372e-01 | 0.077 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.381372e-01 | 0.077 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.381372e-01 | 0.077 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.381372e-01 | 0.077 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.381372e-01 | 0.077 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.381372e-01 | 0.077 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.387281e-01 | 0.076 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.387281e-01 | 0.076 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.387281e-01 | 0.076 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.387281e-01 | 0.076 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 8.387281e-01 | 0.076 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.388603e-01 | 0.076 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.404178e-01 | 0.076 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.443094e-01 | 0.073 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.503332e-01 | 0.070 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.531252e-01 | 0.069 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.531252e-01 | 0.069 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.531252e-01 | 0.069 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.531252e-01 | 0.069 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.531252e-01 | 0.069 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 8.531252e-01 | 0.069 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.566501e-01 | 0.067 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.566501e-01 | 0.067 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.566501e-01 | 0.067 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 8.566501e-01 | 0.067 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.566501e-01 | 0.067 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 8.566501e-01 | 0.067 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.566501e-01 | 0.067 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.566501e-01 | 0.067 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.566501e-01 | 0.067 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 8.566501e-01 | 0.067 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.566501e-01 | 0.067 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.566501e-01 | 0.067 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.628036e-01 | 0.064 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.628036e-01 | 0.064 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.663400e-01 | 0.062 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.663400e-01 | 0.062 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.679332e-01 | 0.062 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.730466e-01 | 0.059 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.730466e-01 | 0.059 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.735589e-01 | 0.059 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.747878e-01 | 0.058 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.784543e-01 | 0.056 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.784543e-01 | 0.056 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.784543e-01 | 0.056 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.786218e-01 | 0.056 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.831365e-01 | 0.054 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.835603e-01 | 0.054 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.835603e-01 | 0.054 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.851519e-01 | 0.053 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.875685e-01 | 0.052 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 8.875685e-01 | 0.052 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.875685e-01 | 0.052 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.875685e-01 | 0.052 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.875685e-01 | 0.052 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.875685e-01 | 0.052 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.875685e-01 | 0.052 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.895471e-01 | 0.051 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.895471e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.895471e-01 | 0.051 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.895471e-01 | 0.051 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.895471e-01 | 0.051 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.899064e-01 | 0.051 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.928497e-01 | 0.049 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.928497e-01 | 0.049 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.996934e-01 | 0.046 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.004300e-01 | 0.046 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.004300e-01 | 0.046 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 9.004300e-01 | 0.046 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.004300e-01 | 0.046 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.004300e-01 | 0.046 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 9.004300e-01 | 0.046 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.004300e-01 | 0.046 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.014683e-01 | 0.045 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.041714e-01 | 0.044 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.080355e-01 | 0.042 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.089646e-01 | 0.041 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.089646e-01 | 0.041 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.089646e-01 | 0.041 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.089646e-01 | 0.041 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.089646e-01 | 0.041 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.094560e-01 | 0.041 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.102905e-01 | 0.041 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.108982e-01 | 0.041 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.118209e-01 | 0.040 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.118209e-01 | 0.040 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.118209e-01 | 0.040 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.118209e-01 | 0.040 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.118209e-01 | 0.040 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.118209e-01 | 0.040 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.118209e-01 | 0.040 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.118209e-01 | 0.040 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.118209e-01 | 0.040 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.118209e-01 | 0.040 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.118209e-01 | 0.040 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.118209e-01 | 0.040 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.118209e-01 | 0.040 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.118209e-01 | 0.040 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.168513e-01 | 0.038 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.174281e-01 | 0.037 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.174281e-01 | 0.037 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.202538e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.205623e-01 | 0.036 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.205623e-01 | 0.036 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.215182e-01 | 0.035 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.219093e-01 | 0.035 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.219093e-01 | 0.035 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.219093e-01 | 0.035 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.219093e-01 | 0.035 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.219093e-01 | 0.035 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.219093e-01 | 0.035 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.219093e-01 | 0.035 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.219093e-01 | 0.035 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.219093e-01 | 0.035 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.219093e-01 | 0.035 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.219093e-01 | 0.035 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.219093e-01 | 0.035 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.219093e-01 | 0.035 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.229849e-01 | 0.035 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.236917e-01 | 0.034 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.251472e-01 | 0.034 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.266559e-01 | 0.033 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.280950e-01 | 0.032 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.300127e-01 | 0.032 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.307395e-01 | 0.031 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.308440e-01 | 0.031 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.308440e-01 | 0.031 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.308440e-01 | 0.031 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.308440e-01 | 0.031 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.308440e-01 | 0.031 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.308440e-01 | 0.031 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.321816e-01 | 0.030 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.321816e-01 | 0.030 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.348944e-01 | 0.029 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.358487e-01 | 0.029 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.385867e-01 | 0.028 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.387569e-01 | 0.027 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.387569e-01 | 0.027 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.412322e-01 | 0.026 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.412322e-01 | 0.026 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.457648e-01 | 0.024 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.457648e-01 | 0.024 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.457648e-01 | 0.024 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.457648e-01 | 0.024 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.457648e-01 | 0.024 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.457648e-01 | 0.024 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.457648e-01 | 0.024 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.460776e-01 | 0.024 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.487217e-01 | 0.023 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.497132e-01 | 0.022 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.497132e-01 | 0.022 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.497132e-01 | 0.022 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.519712e-01 | 0.021 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.519712e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.519712e-01 | 0.021 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.519712e-01 | 0.021 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.519712e-01 | 0.021 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.535245e-01 | 0.021 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.543941e-01 | 0.020 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.545275e-01 | 0.020 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.545820e-01 | 0.020 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.545820e-01 | 0.020 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.549698e-01 | 0.020 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.574676e-01 | 0.019 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.574676e-01 | 0.019 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.574676e-01 | 0.019 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.574676e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.574676e-01 | 0.019 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.574676e-01 | 0.019 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.588988e-01 | 0.018 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.588988e-01 | 0.018 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.614761e-01 | 0.017 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.623354e-01 | 0.017 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.623913e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.628656e-01 | 0.016 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.633511e-01 | 0.016 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.645467e-01 | 0.016 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.647381e-01 | 0.016 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.659689e-01 | 0.015 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.664630e-01 | 0.015 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.666463e-01 | 0.015 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.666463e-01 | 0.015 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.666463e-01 | 0.015 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.673885e-01 | 0.014 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.697237e-01 | 0.013 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.697237e-01 | 0.013 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.704640e-01 | 0.013 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.704640e-01 | 0.013 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.704640e-01 | 0.013 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.704640e-01 | 0.013 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.704640e-01 | 0.013 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.707228e-01 | 0.013 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.713973e-01 | 0.013 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.726776e-01 | 0.012 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.726776e-01 | 0.012 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.734334e-01 | 0.012 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.734334e-01 | 0.012 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.738449e-01 | 0.012 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.738449e-01 | 0.012 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.738449e-01 | 0.012 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.746894e-01 | 0.011 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.757740e-01 | 0.011 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.767607e-01 | 0.010 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.768390e-01 | 0.010 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.768390e-01 | 0.010 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.768390e-01 | 0.010 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.768390e-01 | 0.010 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.777727e-01 | 0.010 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.783332e-01 | 0.010 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.788963e-01 | 0.009 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.794905e-01 | 0.009 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.794905e-01 | 0.009 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.794905e-01 | 0.009 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.794905e-01 | 0.009 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.799622e-01 | 0.009 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.804339e-01 | 0.009 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.818386e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.818386e-01 | 0.008 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.819419e-01 | 0.008 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.820323e-01 | 0.008 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.839180e-01 | 0.007 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.842059e-01 | 0.007 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.853890e-01 | 0.006 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.857594e-01 | 0.006 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.857594e-01 | 0.006 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.868070e-01 | 0.006 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.876998e-01 | 0.005 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.881246e-01 | 0.005 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.881246e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.882830e-01 | 0.005 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.888217e-01 | 0.005 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.888341e-01 | 0.005 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.897266e-01 | 0.004 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.901128e-01 | 0.004 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.903227e-01 | 0.004 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.903860e-01 | 0.004 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.920580e-01 | 0.003 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.922247e-01 | 0.003 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.922479e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.925976e-01 | 0.003 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.926124e-01 | 0.003 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.931358e-01 | 0.003 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.931358e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.937179e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.937454e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.939221e-01 | 0.003 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.939221e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.939221e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.939221e-01 | 0.003 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.946184e-01 | 0.002 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.946184e-01 | 0.002 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.946184e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.948217e-01 | 0.002 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.949290e-01 | 0.002 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.952349e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.952349e-01 | 0.002 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.955842e-01 | 0.002 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.957808e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.957808e-01 | 0.002 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.958655e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.961762e-01 | 0.002 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.961762e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.961762e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.962642e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.963067e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.966923e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.966923e-01 | 0.001 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.967690e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.968653e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.973685e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.974069e-01 | 0.001 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.976192e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.976192e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.977041e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.977794e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.979158e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.979672e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.979672e-01 | 0.001 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.985892e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.986184e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.987174e-01 | 0.001 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.987445e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.987509e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.988920e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.988920e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.989668e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.990209e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.990375e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.990387e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.991332e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.992036e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.992244e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.992325e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.992325e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.992401e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.992618e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.992825e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.992868e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.992868e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.994882e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.994963e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.995419e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.996305e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996718e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.996718e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.997104e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.997104e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.997421e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.997651e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.997730e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.997730e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998060e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998221e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.998425e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.998469e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998497e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998812e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.998908e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999033e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.999033e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999174e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999329e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999353e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999535e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999554e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999604e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999633e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999690e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999690e-01 | 0.000 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.999714e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999714e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999747e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999747e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999753e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999830e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999860e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999885e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999913e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999937e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999939e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999965e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999970e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999971e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999975e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999983e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999989e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999992e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999995e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999997e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999997e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |